Choroba refluksowa przełyku
Epidemiologia

Choroba refluksowa przełyku (GERD) dotyka około 14% populacji światowej, z wyraźnymi różnicami geograficznymi – najwyższa częstość występowania w Ameryce Północnej (18,1-27,8%), a najniższa w Azji Wschodniej (2,5-7,8%). W Polsce objawy GERD zgłasza 36% dorosłych. Od lat 90. XX wieku częstość występowania wzrosła o około 50%, szczególnie w krajach zachodnich i Azji Wschodniej, choć ostatnio tempo wzrostu spowolniło. Czynniki ryzyka obejmują wiek (zwłaszcza >40 lat), otyłość (iloraz szans 1,70 dla otyłości), palenie tytoniu (częstość 18,4% u palaczy), płeć męską (większe ryzyko powikłań), dietę bogatą w tłuszcze, napoje gazowane i kofeinę, a także stres i czynniki socjoekonomiczne. GERD jest także powszechne w populacji pediatrycznej (12-50%) oraz wśród kobiet w ciąży (do 60% w III trymestrze). Diagnostyka opiera się na obrazie klinicznym, endoskopii i badaniu pH, a endoskopowa biopsja jest kluczowa w wykrywaniu przełyku Barretta.

Epidemiologia choroby refluksowej przełyku

Choroba refluksowa przełyku (GERD) stanowi jedno z najczęstszych schorzeń przewodu pokarmowego na świecie, które charakteryzuje się wstecznym przepływem treści żołądkowej do przełyku. Ze względu na swoją powszechność, GERD stanowi istotne obciążenie dla systemów opieki zdrowotnej na całym świecie i wpływa na jakość życia milionów pacjentów.12

Globalna częstotliwość występowania

Szacowana częstość występowania GERD na świecie wynosi około 13,98% populacji ogólnej, co przekłada się na około 1,03 miliarda osób cierpiących na to schorzenie.34 Istnieją jednak znaczne różnice geograficzne w rozpowszechnieniu tej choroby. Częstość występowania GERD szacuje się na:

  • 18,1-27,8% w Ameryce Północnej56
  • 8,8-25,9% w Europie78
  • 2,5-7,8% w Azji Wschodniej910
  • 8,7-33,1% na Bliskim Wschodzie1112
  • 11,6% w Australii1314
  • 23,0% w Ameryce Południowej1516

W Polsce, według badania przeprowadzonego na grupie 850 osób w wieku 21-76 lat, objawy GERD zgłosiło 36% respondentów.17

Trendy epidemiologiczne

Badania wskazują, że częstość występowania GERD wzrosła o około 50% od lat 90. XX wieku, szczególnie w Ameryce Północnej i Azji Wschodniej, chociaż od połowy lat 90. trend ten uległ spowolnieniu.1819 W krajach azjatyckich zaobserwowano wzrost częstości występowania GERD w ostatnich dekadach, choć nadal pozostaje ona niższa niż w populacjach zachodnich.2021

W Chinach zaobserwowano wzrost częstości występowania GERD z 6,0% na początku XXI wieku do 10,6% obecnie, co stanowi znaczącą zmianę.22 Podobne trendy wzrostowe odnotowano w innych częściach świata.

Zapadalność na GERD

Dane dotyczące zapadalności na GERD są bardziej ograniczone niż dane dotyczące chorobowości. W Wielkiej Brytanii i Stanach Zjednoczonych zapadalność szacuje się na około 5 przypadków na 1000 osobolat w populacji ogólnej.23 W populacji pediatrycznej w Wielkiej Brytanii zapadalność wynosi 0,84 na 1000 osobolat u pacjentów w wieku 1-17 lat.24

W Iranie odnotowano zapadalność na GERD wynoszącą od 1,77% do 2,80%, podczas gdy w Chinach zapadalność refluksowego zapalenia przełyku w endoskopiach wykonywanych w populacji otwartej wynosiła 5%.25

Czynniki ryzyka i grupy szczególnego ryzyka

Czynniki demograficzne

Istnieje kilka dobrze rozpoznanych czynników ryzyka rozwoju GERD i jego powikłań:26

Wiek: Częstość występowania GERD zwiększa się z wiekiem, szczególnie po 40. roku życia.2728 Chociaż związek między zaawansowanym wiekiem a objawami GERD jest niekonsekwentny, zaawansowany wiek jest silniej związany z powikłaniami GERD.2930

Płeć: W Ameryce Północnej i Europie nie ma związku między płcią a objawami GERD, ale w Ameryce Południowej i na Bliskim Wschodzie kobiety mają około 40% większe prawdopodobieństwo zgłaszania objawów GERD niż mężczyźni.31 Mężczyźni są jednak bardziej narażeni na refluksowe zapalenie przełyku, zwężenia przełyku, przełyk Barretta i gruczolakoraka przełyku.3233

Badania wskazują, że kobiety częściej cierpią na nieerozyjną chorobę refluksową (NERD) i objawowy GERD, podczas gdy mężczyźni częściej rozwijają cięższe formy zapalenia przełyku i powikłania.3435

Rasa i pochodzenie etniczne: W Stanach Zjednoczonych podobna częstość występowania objawów GERD występuje wśród różnych ras.36 Jednakże osoby rasy białej są bardziej narażone na refluksowe zapalenie przełyku, zwężenia, przełyk Barretta i gruczolakoraka przełyku.3738

Czynniki stylu życia i zdrowotne

Masa ciała i otyłość: Badania wykazały, że częstość występowania GERD wzrasta wraz ze wzrostem BMI.39 Związek GERD z nadwagą ma iloraz szans wynoszący 1,33 (95% CI: 1,07-1,64), a z otyłością – iloraz szans wynoszący 1,70 (95% CI: 1,36-2,12).40 W Stanach Zjednoczonych rosnąca epidemia otyłości jest skorelowana ze zwiększoną częstością występowania GERD.41

Palenie tytoniu: Osoby aktualnie palące mają wyższą częstość występowania GERD (18,40%) w porównaniu z byłymi palaczami (16,83%) i osobami niepalącymi (15,55%).42 Palenie tytoniu jest niezależnym predyktorem GERD.43

Spożycie alkoholu: Wpływ alkoholu na GERD pozostaje niejednoznaczny. Niektóre badania sugerują brak istotnych różnic w częstości występowania GERD między osobami niepijącymi lub pijącymi niewielkie ilości alkoholu (15,95%) a osobami spożywającymi umiarkowane do dużych ilości alkoholu (15,56%).44

Dieta: Spożywanie dużych ilości tłustych pokarmów, czekolady oraz napojów gazowanych i kofeiny wiąże się ze zwiększonym ryzykiem GERD.4546 Osoby spożywające umiarkowane/duże ilości napojów gazowanych miały wyższą częstość występowania GERD niż osoby spożywające niewielkie ilości lub wcale (18,60% vs 14,54%).47

Stres: Wysoki poziom stresu jest istotnie związany z GERD i jest niezależnym predyktorem tego schorzenia.48 W badaniu przeprowadzonym wśród studentów medycyny 23,7% doświadczało wysokiego poziomu postrzeganego stresu, a uczestnicy doświadczający wysokiego poziomu stresu byli bardziej narażeni na rozwinięcie GERD.49

Czynniki socjo-ekonomiczne

Wykształcenie: Najwyższą częstość występowania GERD stwierdzono u osób z niskim poziomem wykształcenia (16,78%), następnie u osób ze średnim poziomem wykształcenia (11,52%), a najniższą częstość występowania GERD odnotowano u osób z wysokim poziomem wykształcenia (8,98%).50

Dochód: Osoby o niskich dochodach miały znacznie wyższą częstość występowania GERD (11,69%) niż osoby o średnich dochodach (8,42%) i osoby o wysokich dochodach (7,68%).51

Stan cywilny: Najwyższą częstość występowania GERD stwierdzono u osób rozwiedzionych/w separacji/owdowiałych (22,95%), następnie u osób pozostających w związku małżeńskim (15,98%), a najniższą częstość występowania GERD odnotowano u osób stanu wolnego (12,85%).52

Grupy szczególnego ryzyka

Kobiety w ciąży: Częstość występowania GERD wzrasta w trakcie ciąży, dotykając 20-30% kobiet w pierwszym trymestrze, 40-45% w drugim trymestrze i 60% w trzecim trymestrze.53 Zwiększone ciśnienie w jamie brzusznej sprawia, że kobiety w ciąży są bardziej narażone na objawy GERD.54

Dzieci i młodzież: GERD występuje również w populacji pediatrycznej, a jego częstość wzrasta. Nelson i wsp. odnotowali częstość występowania GERD wynoszącą od 12% do 50% u dzieci w wieku 0-18 lat w latach 2000-2005.5556

Studenci medycyny: Badania wskazują, że GERD jest coraz częstszym schorzeniem wśród studentów medycyny. W Egipcie częstość występowania GERD wśród studentów medycyny wynosiła 17,1%, co jest uznawane za stosunkowo wysoką wartość.57 W innym badaniu przeprowadzonym w Egipcie częstość występowania GERD wśród studentów medycyny wynosiła 28,4%.58

Osoby z cukrzycą typu 2: Chociaż niektóre badania sugerują, że cukrzyca typu 2 jest czynnikiem ryzyka objawowego GERD, inne nie wykazały istotnych różnic w częstości występowania GERD między pacjentami z cukrzycą typu 2 a grupą kontrolną.5960

Wpływ choroby refluksowej na zdrowie publiczne

Obciążenie gospodarcze

GERD jest odpowiedzialny za największe bezpośrednie koszty w Stanach Zjednoczonych spośród wszystkich chorób układu pokarmowego, a większość tych wydatków przeznaczana jest na farmakoterapię.61 W 2018 roku roczne wydatki na opiekę zdrowotną związane z zaburzeniami przełyku przekroczyły 12 miliardów dolarów w Stanach Zjednoczonych.62

Według niedawnego badania dotyczącego obciążenia przewlekłymi zaburzeniami żołądkowo-jelitowymi, GERD okazał się najdroższym schorzeniem, z bezpośrednimi i pośrednimi kosztami wynoszącymi 10 miliardów dolarów rocznie.63

W Stanach Zjednoczonych 4,6 miliona wizyt w gabinecie rocznie jest związanych głównie z GERD, podczas gdy 9,1 miliona wizyt uwzględnia GERD w trzech głównych diagnozach.64 GERD stanowi również najczęściej wymienianą diagnozę gastroenterologiczną w wizytach ambulatoryjnych.65

Według niektórych szacunków, wydatki na pozaprzełykowe objawy refluksu mogą przekraczać 50 miliardów dolarów, z czego 86% może być przypisane kosztom farmaceutycznym.66

Wpływ na jakość życia

GERD ma negatywny wpływ na jakość życia pacjentów.67 Zmniejszona produktywność i aktywność fizyczna są zgłaszane szczególnie przez pacjentów z częstymi objawami.68

Pacjenci, którzy spełniają kryteria GERD, często doświadczają poważnego negatywnego wpływu objawów na jakość życia.69 Uciążliwy GERD (objawy częściej niż raz w tygodniu) zwiększa czas nieobecności pracowników w pracy i zmniejsza wydajność pracy.70

Nocny GERD ma większy negatywny wpływ na jakość życia w porównaniu z objawami dziennymi.71 W ogólnokrajowym badaniu obejmującym 1000 dorosłych z zgagą występującą co najmniej raz w tygodniu, 79% zgłosiło nocną zgagę.72

Powikłania związane z GERD

Przewlekły GERD może prowadzić do szeregu powikłań, które dodatkowo zwiększają obciążenie zdrowotne:73

  • Refluksowe zapalenie przełyku: W badaniach populacyjnych opartych na pacjentach zgadzających się na endoskopię niezależnie od objawów, częstość występowania refluksowego zapalenia przełyku wahała się od 6,4% w Chinach do 15,5% w Szwecji.74 Wśród osób bez objawów GERD częstość występowania refluksowego zapalenia przełyku wahała się od 6,1% w Chinach do 9,5% w Szwecji.75
  • Przełyk Barretta: GERD jest czynnikiem ryzyka przełyku Barretta, który dotyczy około 2% populacji i może prowadzić do gruczolakoraka przełyku.76 Tylko 10% osób z objawowym GERD ma przełyk Barretta.77
  • Gruczolakorak przełyku: GERD zwiększa ryzyko gruczolakoraka przełyku (iloraz szans [OR], 7,7; 95% CI, 5,3-11,4), szczególnie u pacjentów z długotrwałym GERD oraz ciężkimi lub codziennymi objawami.78 Ryzyko to jest jednak niskie i wynosi mniej niż 0,001% rocznie.79
  • Zwężenia przełyku: Kwas żołądkowy może prowadzić do uszkodzenia tkanki przełyku, powodując stan zapalny, krwawienia, a czasami owrzodzenia.80
  • Pozaprzełykowe manifestacje: GERD jest szeroko związany z astmą, przewlekłym kaszlem i zapaleniem krtani.81 Częstość występowania GERD u pacjentów z astmą waha się od 30% do 90% w różnych populacjach.82 W systematycznym przeglądzie analizującym 28 badań zaobserwowano 59,2% średnią ważoną częstość występowania objawów GERD u pacjentów z astmą, podczas gdy tylko 38,1% osób z grupy kontrolnej miało te objawy.83

Sezonowe i geograficzne zróżnicowanie GERD

Zróżnicowanie sezonowe

Interesujące są obserwacje dotyczące sezonowych wahań w częstości występowania GERD. Badanie przeprowadzone na Tajwanie przez Chen i wsp. wykazało zmienność sezonową w występowaniu GERD. Badacze ocenili łącznie 76 636 ambulatoryjnych wizyt związanych z leczeniem GERD w latach 2001-2006 i odnotowali, że częstość występowania GERD wzrastała jesienią i zimą dla każdej płci, grupy wiekowej oraz grup łączonych.84

Zróżnicowanie geograficzne

Istnieją znaczne różnice geograficzne w rozpowszechnieniu GERD. Częstość występowania GERD była wyższa na zachodzie i wschodzie Chin niż w centrum, z możliwą lokalną autokorelacją przestrzenną między Wyżyną Tybetańsko-Qinghai a południowym wschodem.85

W Stanach Zjednoczonych szwedzkie badanie populacyjne, przekrojowe porównało częstość występowania objawów refluksu żołądkowo-przełykowego wśród populacji angielskiej i szwedzkiej i wykazało wyższą częstość występowania objawów refluksu występujących co najmniej dwa razy w tygodniu w populacjach angielskich w porównaniu z populacjami szwedzkimi.86

W Azji, częstość występowania GERD w Iranie wynosiła 6,3-18,3% w latach 2005-2010, co wydaje się bardziej powszechne niż w Azji Wschodniej.87 Częstość występowania w Azji Zachodniej okazała się najwyższa w całym regionie azjatyckim, reprezentowana przez 20% w Turcji.88

Metody monitorowania i nadzoru epidemiologicznego

Badania populacyjne

Większość badań epidemiologicznych dotyczących GERD opiera się na objawach. Ponieważ diagnoza oparta na objawach jest trudna, dane epidemiologiczne dotyczące częstości występowania objawów refluksu żołądkowo-przełykowego (GERS) są prawdopodobnie niedoskonałe.89 Częściowo wynika to z faktu, że opis i nomenklatura objawów refluksu różnią się między regionami, a częściowo dlatego, że objawy z górnego odcinka przewodu pokarmowego (dyspeptyczne/” title=”objawy dyspeptyczne” class=”to-tag” data-termid=”51687″>objawy dyspeptyczne) mogą być podobnie opisywane przez pacjentów, którzy mają różne diagnozy z górnego odcinka przewodu pokarmowego, w tym chorobę wrzodową, dyspepsję bez wrzodów, dysmotorykę lub GERD.90

Warto jednak przedstawić częstość występowania objawów dyspeptycznych na całym świecie, ponieważ dane te wpływają na prawdopodobieństwo przed testem, że objawy z górnego odcinka przewodu pokarmowego można przypisać refluksowi żołądkowo-przełykowemu.91

Badania diagnostyczne i monitorowanie

Diagnostyka GERD jest kliniczna, czasami z endoskopią, z lub bez badania kwasowości.92 Endoskopia, z płukaniem cytologicznym i/lub biopsją nieprawidłowych obszarów, jest testem z wyboru.93 Endoskopowa biopsja jest jedynym testem, który konsekwentnie wykrywa zmiany błony śluzowej kolumnowej w przełyku Barretta.94

Według Konsensusu Lyońskiego, stopnie zapalenia przełyku C i D są obiektywnym dowodem GERD.95 Przełyk Barretta może, ale nie musi ustąpić po leczeniu medycznym lub chirurgicznym.96

Ponieważ przełyk Barretta jest prekursorem gruczolakoraka, zaleca się endoskopowe monitorowanie w kierunku transformacji złośliwej co 3 do 5 lat w przypadku niedysplastycznej choroby.97

Wyzwania w nadzorze epidemiologicznym

Globalna częstość występowania GERD, pomimo powszechnej dyskusji, pozostaje niepewna z powodu kilku czynników. Głównym czynnikiem jest brak powszechnie akceptowanej definicji GERD.98 Po przeanalizowaniu badań z całego świata, wielu ekspertów stosowało zgagę i/lub regurgitację występującą co najmniej raz w tygodniu jako próg dla GERD.99

Wciąż brakuje solidnych badań epidemiologicznych dla krajów rozwiniętych, takich jak Japonia, a także dla wielu wschodzących gospodarek, w tym Rosji, Indii i kontynentu afrykańskiego. Istnieje również niewiele danych dotyczących częstości występowania GERD w populacjach pediatrycznych, zapadalności na GERD, jego naturalnej historii i przyczyn.100

W przeglądzie systematycznym z 2020 roku wykorzystano dane z Global Burden of Diseases, Injuries and Risk Factors Study do przedstawienia obciążenia GERD w 195 krajach w latach 1990-2017. Z danych o częstości występowania ze 144 lokalizacji określono średnie szacunki standaryzowanej według wieku częstości występowania dla wszystkich lokalizacji w 2017 r., które wahały się od 4408 do 14 035 przypadków na 100 000 populacji.101 Chociaż globalna standaryzowana względem wieku częstość występowania była stabilna między 1990 a 2017 rokiem, częstość występowania dla wszystkich grup wiekowych wzrosła o 18,1%, co sugeruje, że epidemiologia GERD nie uległa zmianie, ale obciążenie chorobą wzrasta w wyniku starzenia się i wzrostu populacji.102

Podsumowanie danych epidemiologicznych

Choroba refluksowa przełyku jest globalnym problemem zdrowotnym o znacznym wpływie na jakość życia i obciążenie ekonomiczne. Szacuje się, że dotyka około 14% światowej populacji, z wyraźnymi różnicami geograficznymi – najwyższa częstość występowania jest w Ameryce Północnej i najniższa w Azji Wschodniej.103104

Częstość występowania GERD wzrosła o około 50% od lat 90. XX wieku, szczególnie w krajach zachodnich i Azji Wschodniej, choć wzrost ten uległ spowolnieniu w ostatnich latach.105106 Czynniki ryzyka obejmują otyłość, wiek, płeć męską (dla powikłań), palenie tytoniu, dietę oraz czynniki socjoekonomiczne.107108

GERD wiąże się z istotnymi powikłaniami, takimi jak refluksowe zapalenie przełyku, przełyk Barretta i gruczolakorak przełyku, a także manifestacje pozaprzełykowe, takie jak astma i przewlekły kaszel.109110111

Monitorowanie i nadzór epidemiologiczny GERD napotykają wyzwania związane z brakiem ujednoliconej definicji choroby i ograniczonymi danymi z wielu regionów świata.112113 Niemniej jednak, rosnące obciążenie GERD podkreśla potrzebę kompleksowych strategii zdrowia publicznego w celu zapobiegania, wczesnego wykrywania i skutecznego leczenia tej powszechnej choroby.114

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 10.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Epidemiology, Causes, and Management of Gastro-esophageal Reflux Disease: A Systematic Review
    https://pmc.ncbi.nlm.nih.gov/articles/PMC10658748/
    Our comprehensive systematic review aimed to examine gastroesophageal reflux disease (GERD), a disorder that occurs when stomach contents flow back into the esophagus. […] Millions of individuals worldwide suffer from GERD, a common clinical condition. […] GERD is a common gastrointestinal disorder, affecting around 20% of adults in Western cultures. […] The prevalence in the US ranges from 18.1% to 27.8%, with a slightly higher rate in men. […] GERD is a frequent digestive illness around the world, with a prevalence range of 18.1%-27.8% in North America. […] In the US, the rate of GERD symptoms is over 20%, with 110,000 hospitalizations each year. […] With regional fluctuation, the overall frequency of GERD symptoms is roughly 13%. […] The prevalence range in the US is 6%-30%, with variation depending on the questionnaire utilized. […] GERD is a prevalent disease in the Western world, affecting 10%-20% of the population. […] In the US, the rising obesity epidemic is correlated with an increased prevalence of GERD.
  • #2 A narrative review of the prevalence of gastroesophageal reflux disease (GERD) – Boulton – Annals of Esophagus
    https://aoe.amegroups.org/article/view/6041/html
    Over the years gastroesophageal reflux disease (GERD) has become a common disease worldwide affecting most countries and their populations. […] GERD is increasing in its prevalence worldwide and is defined as a disease that develops due to a chronic retrograde flow of gastric contents from the stomach into the esophagus, oral cavity or lungs. […] The incidence of GERD is high in the general population, it is estimated to affect up to 20% of the population worldwide. […] Nowadays GERD is found to be the most common diagnosis made in a gastroenterology practice. […] A study in 2014 identified and reported the prevalence of GERD at 10-20% in Europe and the USA, but less than 5% in Asia. […] The prevalence of GERD is reported to be higher in western countries compared to eastern countries.
  • #3 Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis | Scientific Reports
    https://www.nature.com/articles/s41598-020-62795-1
    Although gastro-oesophageal reflux disease (GORD) is a common medical complaint, there is currently no consensus on the global prevalence of GORD. […] The global pooled prevalence of GORD was 13.98% and varied greatly according to region (12.88% in Latin America and the Caribbean to 19.55% in North America) and country (4.16% in China to 22.40% in Turkey). […] Using the United Nations 2017 Revision of World Population Prospects, the estimated number of individuals suffering from GORD globally is 1.03 billion. […] This systematic review and meta-analysis revealed that although a substantial proportion (13.98%) of the global population suffers from GORD, there are significant variations between regions and countries. […] A recent systematic review and meta-analysis conducted by Eusebi et al. 2017 included 108 studies and assessed the global prevalence of, and risk factors for, gastric reflux symptoms rather the prevalence of GORD.
  • #4 Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis | Scientific Reports
    https://www.nature.com/articles/s41598-020-62795-1
    Subjects with a moderate/high intake of carbonated drinks had a higher pooled prevalence of GORD than those with low/none intake (18.60% vs 14.54%, respectively). […] Pooling prevalence of GORD according to intake of coffee/tea revealed a higher GORD prevalence in subjects with a moderate/high intake of coffee/tea (21.02%) than those with a low/none intake (16.92%). […] This comprehensive systematic review has demonstrated the significant global burden of GORD with approximately 1.03 billion individuals suffering from the condition globally. […] It has also confirmed substantial variations in the pooled prevalence of GORD between regions and countries.
  • #5 Presentation and Epidemiology of Gastroesophageal Reflux Disease
    https://pmc.ncbi.nlm.nih.gov/articles/PMC5797499/
    Gastroesophageal reflux disease (GERD) is the most prevalent gastrointestinal disorder in the United States, and leads to substantial morbidity, though associated mortality is rare. The prevalence of GERD symptoms appeared to increase until 1999. Risk factors for complications of GERD include advanced age, male sex, white race, abdominal obesity, and tobacco use. Most patients with GERD presents with heartburn and effortless regurgitation. […] GERD is exceedingly common, ranking as the most frequent gastrointestinal diagnosis associated with outpatient clinic visits in the United States (US), with nearly 9 million visits in 2009. […] The pooled prevalence of at least weekly GERD symptoms reported from population-based studies worldwide is approximately 13%, but there is considerable geographic variation.
  • #6 Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review | Gut
    https://gut.bmj.com/content/63/6/871
    Objective To update the findings of the 2005 systematic review of population-based studies assessing the epidemiology of gastro-oesophageal reflux disease (GERD). […] Results 16 studies of GERD epidemiology published since the original review were found to be suitable for inclusion (15 reporting prevalence and one reporting incidence), and were added to the 13 prevalence and two incidence studies found previously. The range of GERD prevalence estimates was 18.1%27.8% in North America, 8.8%25.9% in Europe, 2.5%7.8% in East Asia, 8.7%33.1% in the Middle East, 11.6% in Australia and 23.0% in South America. Incidence per 1000 person-years was approximately 5 in the overall UK and US populations, and 0.84 in paediatric patients aged 117years in the UK. Evidence suggests an increase in GERD prevalence since 1995 (p0.0001), particularly in North America and East Asia. […] Conclusions GERD is prevalent worldwide, and disease burden may be increasing. Prevalence estimates show considerable geographic variation, but only East Asia shows estimates consistently lower than 10%.
  • #7 Diagnostic and therapeutic management in gastroesophageal reflux disease: consensus of the Polish Society of Gastroenterology – Polish Archives of Internal Medicine
    https://www.mp.pl/paim/issue/article/16196/
    GERD prevalence is estimated at approximately 20%, based on the occurrence of heartburn and / or regurgitation 1-2 times a week. […] The prevalence of GERD is estimated at 8.8%25.9% in Europe, 2.5%7.8% in Asia, 8.7%33.1% in the Middle East, 11.6% in Australia, and 23% in South Africa. […] About 2540% of American adults report heartburn at least once a month, and about 7%10% of patients experience heartburn every day. […] In Poland, among 850 people aged 21-76, GERD symptoms were reported by 36% of the respondents. […] GERD has a negative impact on the patients quality of life. […] Reduced productivity and physical activity are especially reported by patients with frequent symptoms. […] GERD is equally common among men and women but complications are more common in men: erosive esophagitis (about 2 times more often), Barretts esophagus (BE) (about 10 times), and esophageal adenocarcinoma (about 8 times).
  • #8 Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review | Gut
    https://gut.bmj.com/content/63/6/871
    Objective To update the findings of the 2005 systematic review of population-based studies assessing the epidemiology of gastro-oesophageal reflux disease (GERD). […] Results 16 studies of GERD epidemiology published since the original review were found to be suitable for inclusion (15 reporting prevalence and one reporting incidence), and were added to the 13 prevalence and two incidence studies found previously. The range of GERD prevalence estimates was 18.1%27.8% in North America, 8.8%25.9% in Europe, 2.5%7.8% in East Asia, 8.7%33.1% in the Middle East, 11.6% in Australia and 23.0% in South America. Incidence per 1000 person-years was approximately 5 in the overall UK and US populations, and 0.84 in paediatric patients aged 117years in the UK. Evidence suggests an increase in GERD prevalence since 1995 (p0.0001), particularly in North America and East Asia. […] Conclusions GERD is prevalent worldwide, and disease burden may be increasing. Prevalence estimates show considerable geographic variation, but only East Asia shows estimates consistently lower than 10%.
  • #9 Diagnostic and therapeutic management in gastroesophageal reflux disease: consensus of the Polish Society of Gastroenterology – Polish Archives of Internal Medicine
    https://www.mp.pl/paim/issue/article/16196/
    GERD prevalence is estimated at approximately 20%, based on the occurrence of heartburn and / or regurgitation 1-2 times a week. […] The prevalence of GERD is estimated at 8.8%25.9% in Europe, 2.5%7.8% in Asia, 8.7%33.1% in the Middle East, 11.6% in Australia, and 23% in South Africa. […] About 2540% of American adults report heartburn at least once a month, and about 7%10% of patients experience heartburn every day. […] In Poland, among 850 people aged 21-76, GERD symptoms were reported by 36% of the respondents. […] GERD has a negative impact on the patients quality of life. […] Reduced productivity and physical activity are especially reported by patients with frequent symptoms. […] GERD is equally common among men and women but complications are more common in men: erosive esophagitis (about 2 times more often), Barretts esophagus (BE) (about 10 times), and esophageal adenocarcinoma (about 8 times).
  • #10 Epidemiology of Gastroesophageal Reflux Disease in Asia: A Systematic Review
    https://www.jnmjournal.org/view.html?uid=385&vmd=Full
    The prevalence of GERD has been increased in Eastern Asia, but still lower than those of the Western population. The prevalence of GERD in Southeast and Western Asia was higher than in Eastern Asia. […] The prevalence of endoscopic reflux esophagitis in Eastern Asia seemed to increase in participants who have received the medical check-up. […] In Asia, only few and limited studies have been reported regarding the proportion of extra-esophageal syndromes such as asthma, sleep disturbance, non-cardiac chest pain and dental erosion, which was found to be significantly higher in the GERD patient group than controls.
  • #11 Diagnostic and therapeutic management in gastroesophageal reflux disease: consensus of the Polish Society of Gastroenterology – Polish Archives of Internal Medicine
    https://www.mp.pl/paim/issue/article/16196/
    GERD prevalence is estimated at approximately 20%, based on the occurrence of heartburn and / or regurgitation 1-2 times a week. […] The prevalence of GERD is estimated at 8.8%25.9% in Europe, 2.5%7.8% in Asia, 8.7%33.1% in the Middle East, 11.6% in Australia, and 23% in South Africa. […] About 2540% of American adults report heartburn at least once a month, and about 7%10% of patients experience heartburn every day. […] In Poland, among 850 people aged 21-76, GERD symptoms were reported by 36% of the respondents. […] GERD has a negative impact on the patients quality of life. […] Reduced productivity and physical activity are especially reported by patients with frequent symptoms. […] GERD is equally common among men and women but complications are more common in men: erosive esophagitis (about 2 times more often), Barretts esophagus (BE) (about 10 times), and esophageal adenocarcinoma (about 8 times).
  • #12 The Changing Epidemiology of Gastroesophageal Reflux Disease: Are Patients Getting Younger?
    https://www.jnmjournal.org/journal/view.html?doi=10.5056/jnm18140
    Gastroesophageal reflux disease (GERD) is a common disease globally with increasing prevalence and consequently greater burden on the Healthcare system. […] Over the last decade, there has been a significant increase in the proportion of younger patients with GERD, especially those within the age range of 30-39 years. […] The prevalence of GERD is 18.1-27.8% in North America, 8.8-25.9% in Europe, 2.5-7.8% in East Asia, 8.7-33.1% in the Middle East, 11.6% in Australia, and 23.0% in South America. […] As risk factors for GERD increasingly affect the general population, concerns have been raised that more young individuals will develop GERD and its potential consequences. […] The proportion of patients with GERD has increased in all age groups, with the exception of those who were aged 70 years in both the universal and Healthcare system datasets.
  • #13 The Changing Epidemiology of Gastroesophageal Reflux Disease: Are Patients Getting Younger?
    https://www.jnmjournal.org/journal/view.html?doi=10.5056/jnm18140
    Gastroesophageal reflux disease (GERD) is a common disease globally with increasing prevalence and consequently greater burden on the Healthcare system. […] Over the last decade, there has been a significant increase in the proportion of younger patients with GERD, especially those within the age range of 30-39 years. […] The prevalence of GERD is 18.1-27.8% in North America, 8.8-25.9% in Europe, 2.5-7.8% in East Asia, 8.7-33.1% in the Middle East, 11.6% in Australia, and 23.0% in South America. […] As risk factors for GERD increasingly affect the general population, concerns have been raised that more young individuals will develop GERD and its potential consequences. […] The proportion of patients with GERD has increased in all age groups, with the exception of those who were aged 70 years in both the universal and Healthcare system datasets.
  • #14 Diagnostic and therapeutic management in gastroesophageal reflux disease: consensus of the Polish Society of Gastroenterology – Polish Archives of Internal Medicine
    https://www.mp.pl/paim/issue/article/16196/
    GERD prevalence is estimated at approximately 20%, based on the occurrence of heartburn and / or regurgitation 1-2 times a week. […] The prevalence of GERD is estimated at 8.8%25.9% in Europe, 2.5%7.8% in Asia, 8.7%33.1% in the Middle East, 11.6% in Australia, and 23% in South Africa. […] About 2540% of American adults report heartburn at least once a month, and about 7%10% of patients experience heartburn every day. […] In Poland, among 850 people aged 21-76, GERD symptoms were reported by 36% of the respondents. […] GERD has a negative impact on the patients quality of life. […] Reduced productivity and physical activity are especially reported by patients with frequent symptoms. […] GERD is equally common among men and women but complications are more common in men: erosive esophagitis (about 2 times more often), Barretts esophagus (BE) (about 10 times), and esophageal adenocarcinoma (about 8 times).
  • #15 The Changing Epidemiology of Gastroesophageal Reflux Disease: Are Patients Getting Younger?
    https://www.jnmjournal.org/journal/view.html?doi=10.5056/jnm18140
    Gastroesophageal reflux disease (GERD) is a common disease globally with increasing prevalence and consequently greater burden on the Healthcare system. […] Over the last decade, there has been a significant increase in the proportion of younger patients with GERD, especially those within the age range of 30-39 years. […] The prevalence of GERD is 18.1-27.8% in North America, 8.8-25.9% in Europe, 2.5-7.8% in East Asia, 8.7-33.1% in the Middle East, 11.6% in Australia, and 23.0% in South America. […] As risk factors for GERD increasingly affect the general population, concerns have been raised that more young individuals will develop GERD and its potential consequences. […] The proportion of patients with GERD has increased in all age groups, with the exception of those who were aged 70 years in both the universal and Healthcare system datasets.
  • #16 Diagnostic and therapeutic management in gastroesophageal reflux disease: consensus of the Polish Society of Gastroenterology – Polish Archives of Internal Medicine
    https://www.mp.pl/paim/issue/article/16196/
    GERD prevalence is estimated at approximately 20%, based on the occurrence of heartburn and / or regurgitation 1-2 times a week. […] The prevalence of GERD is estimated at 8.8%25.9% in Europe, 2.5%7.8% in Asia, 8.7%33.1% in the Middle East, 11.6% in Australia, and 23% in South Africa. […] About 2540% of American adults report heartburn at least once a month, and about 7%10% of patients experience heartburn every day. […] In Poland, among 850 people aged 21-76, GERD symptoms were reported by 36% of the respondents. […] GERD has a negative impact on the patients quality of life. […] Reduced productivity and physical activity are especially reported by patients with frequent symptoms. […] GERD is equally common among men and women but complications are more common in men: erosive esophagitis (about 2 times more often), Barretts esophagus (BE) (about 10 times), and esophageal adenocarcinoma (about 8 times).
  • #17 Diagnostic and therapeutic management in gastroesophageal reflux disease: consensus of the Polish Society of Gastroenterology – Polish Archives of Internal Medicine
    https://www.mp.pl/paim/issue/article/16196/
    GERD prevalence is estimated at approximately 20%, based on the occurrence of heartburn and / or regurgitation 1-2 times a week. […] The prevalence of GERD is estimated at 8.8%25.9% in Europe, 2.5%7.8% in Asia, 8.7%33.1% in the Middle East, 11.6% in Australia, and 23% in South Africa. […] About 2540% of American adults report heartburn at least once a month, and about 7%10% of patients experience heartburn every day. […] In Poland, among 850 people aged 21-76, GERD symptoms were reported by 36% of the respondents. […] GERD has a negative impact on the patients quality of life. […] Reduced productivity and physical activity are especially reported by patients with frequent symptoms. […] GERD is equally common among men and women but complications are more common in men: erosive esophagitis (about 2 times more often), Barretts esophagus (BE) (about 10 times), and esophageal adenocarcinoma (about 8 times).
  • #18 Presentation and Epidemiology of Gastroesophageal Reflux Disease
    https://pmc.ncbi.nlm.nih.gov/articles/PMC5797499/
    In the US, estimates of the prevalence of GERD symptoms have ranged from 6% to 30%, with heterogeneity related to the particular questionnaire used, including the threshold frequency and duration of symptoms required to be classified as GERD. The prevalence of at least weekly GERD symptoms in the US is approximately 20%. […] Importantly, the prevalence of GERD symptoms in North America, Europe, and Southeast Asia has increased approximately 50% relative to the baseline prevalence in the early to middle 1990s, but has plateaued since then. […] There are approximately 110,000 hospital admissions annually in the US for GERD. […] The predominant complications of GERD include dysphagia (including from peptic strictures, Schatzkis rings), bleeding from erosive esophagitis, and esophageal adenocarcinoma.
  • #19 Epidemiology of gastroesophageal reflux disease | WHO FCTC
    https://portal-uat.who.int/fctcapps/fctcapps/fctc/kh/wts/wts-database/epidemiology-gastroesophageal-reflux-disease
    The prevalence of gastroesophageal reflux disease (GERD) symptoms increased approximately 50% until the mid-1990s, when it plateaued. […] The incidence of complications related to GERD including hospitalization, esophageal strictures, esophageal adenocarcinoma, and mortality also increased during that time period, but the increase in esophageal adenocarcinoma has since slowed, and the incidence of strictures has decreased since the mid-1990s. […] GERD is responsible for the greatest direct costs in the United States of any gastrointestinal disease, and most of those expenditures are for pharmacotherapy. […] Risk factors for GERD include obesity, poor diet, lack of physical activity, consumption of tobacco and alcohol, and respiratory diseases.
  • #20 Epidemiology of Gastroesophageal Reflux Disease in Asia: A Systematic Review
    https://www.jnmjournal.org/view.html?uid=385&vmd=Full
    Epidemiology of Gastroesophageal Reflux Disease in Asia: A Systematic Review […] From the population-based studies, the prevalence of symptom-based GERD in Eastern Asia was found to be 2.5%-4.8% before 2005 and 5.2%-8.5% from 2005 to 2010. In Southeast and Western Asia, it was 6.3%-18.3% after 2005, which was much higher than those in Eastern Asia. […] In summary, the prevalence of symptom-based GERD and endoscopic reflux esophagitis has increased in Asian countries. However, the prevalence of Barrett’s esophagus in Asia has not changed and also still rare. […] During the recent decade, several studies about prevalence of symptom-based GERD and endoscopic reflux esophagitis have revealed generally higher number of patients compared to other previous Asian studies. Time trend studies have also shown the increase of prevalence both in symptom based-GERD and endoscopic reflux esophagitis.
  • #21 Epidemiology of Gastroesophageal Reflux Disease in Asia: A Systematic Review
    https://www.jnmjournal.org/view.html?uid=385&vmd=Full
    The prevalence of GERD has been increased in Eastern Asia, but still lower than those of the Western population. The prevalence of GERD in Southeast and Western Asia was higher than in Eastern Asia. […] The prevalence of endoscopic reflux esophagitis in Eastern Asia seemed to increase in participants who have received the medical check-up. […] In Asia, only few and limited studies have been reported regarding the proportion of extra-esophageal syndromes such as asthma, sleep disturbance, non-cardiac chest pain and dental erosion, which was found to be significantly higher in the GERD patient group than controls.
  • #22 Meta-analysis on the epidemiology of gastroesophageal reflux disease in China
    https://www.wjgnet.com/1007-9327/full/v28/i45/6410.htm
    Meta-analysis on the epidemiology of gastroesophageal reflux disease in China. The overall pooled prevalence of gastroesophageal reflux disease (GERD) was 8.7% in China. Over the past two decades, the prevalence of GERD in China has increased from 6.0% to 10.6%. GERD was more common in people aged 40-60, with body mass index 24, and of Uygur ethnicity. The prevalence was higher in the west and east than in the centre, and there may be a local spatial autocorrelation between the Qinghai-Tibet Plateau and the southeast. GERD was correlated with gastric (r= 0.421,P = 0.041) and oesophageal tumours (r= 0.511,P = 0.011) in spatial distribution. […] The prevalence of GERD in China is rising. From 6.0% at the beginning of the 21st century to 10.6% at present, there was a significant difference in the prevalence among different periods (P= 0.019). […] The prevalence rate of GERD was higher in people who were over 40 years old, obese and of the Uygur population. The prevalence of GERD was positively correlated with that of oesophageal cancer in terms of spatial distribution.
  • #23 Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review | Gut
    https://gut.bmj.com/content/63/6/871
    Objective To update the findings of the 2005 systematic review of population-based studies assessing the epidemiology of gastro-oesophageal reflux disease (GERD). […] Results 16 studies of GERD epidemiology published since the original review were found to be suitable for inclusion (15 reporting prevalence and one reporting incidence), and were added to the 13 prevalence and two incidence studies found previously. The range of GERD prevalence estimates was 18.1%27.8% in North America, 8.8%25.9% in Europe, 2.5%7.8% in East Asia, 8.7%33.1% in the Middle East, 11.6% in Australia and 23.0% in South America. Incidence per 1000 person-years was approximately 5 in the overall UK and US populations, and 0.84 in paediatric patients aged 117years in the UK. Evidence suggests an increase in GERD prevalence since 1995 (p0.0001), particularly in North America and East Asia. […] Conclusions GERD is prevalent worldwide, and disease burden may be increasing. Prevalence estimates show considerable geographic variation, but only East Asia shows estimates consistently lower than 10%.
  • #24 Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review | Gut
    https://gut.bmj.com/content/63/6/871
    Objective To update the findings of the 2005 systematic review of population-based studies assessing the epidemiology of gastro-oesophageal reflux disease (GERD). […] Results 16 studies of GERD epidemiology published since the original review were found to be suitable for inclusion (15 reporting prevalence and one reporting incidence), and were added to the 13 prevalence and two incidence studies found previously. The range of GERD prevalence estimates was 18.1%27.8% in North America, 8.8%25.9% in Europe, 2.5%7.8% in East Asia, 8.7%33.1% in the Middle East, 11.6% in Australia and 23.0% in South America. Incidence per 1000 person-years was approximately 5 in the overall UK and US populations, and 0.84 in paediatric patients aged 117years in the UK. Evidence suggests an increase in GERD prevalence since 1995 (p0.0001), particularly in North America and East Asia. […] Conclusions GERD is prevalent worldwide, and disease burden may be increasing. Prevalence estimates show considerable geographic variation, but only East Asia shows estimates consistently lower than 10%.
  • #25 Diagnosis and treatment of gastroesophageal reflux disease: recommendations of the Asociación Mexicana de Gastroenterología | Revista de Gastroenterología de México
    https://www.revistagastroenterologiamexico.org/en-diagnosis-treatment-gastroesophageal-reflux-disease-articulo-S2255534X16300482
    The international DIGEST study estimated that the prevalence of GERD symptoms is 7.7%, with heartburn as the most frequent (13.5%) of the digestive symptom group. […] In Latin America, there are very few reports in the literature on the prevalence of GERD. […] A systematic review evaluated prevalence studies in the region (a total of 8 studies, one in Argentina, 5 in Brazil, and 2 in Mexico), concluding that there was a 3 to 11.9% prevalence. […] There is very little information on GERD incidence, with no national reports and very few foreign ones. […] A 5% incidence of reflux esophagitis in endoscopies carried out on an open Chinese population was reported, along with a 22.5% incidence in patients with heartburn, whereas a 1.77 to 2.80% incidence of reflux was reported in Iran. […] Some of the most important risk factors for developing GERD are: heredity, overweight, central obesity, smoking, alcohol, and pregnancy.
  • #26 Presentation and Epidemiology of Gastroesophageal Reflux Disease
    https://pmc.ncbi.nlm.nih.gov/articles/PMC5797499/
    In 3 population-based studies of patients agreeing to undergo endoscopy regardless of symptoms, the prevalence of erosive esophagitis ranged from 6.4% in China to 15.5% in Sweden. […] Among individuals without symptoms of GERD, the prevalence of erosive esophagitis ranged from 6.1% in China to 9.5% in Sweden. […] Erosive esophagitis may frequently be a transient phenomenon. […] There are a number of well-recognized risk factors for GERD and its complications. […] In North America and in Europe, there is no association between sex and symptoms of GERD, but in South America and in the Middle East, women are approximately 40% more likely to report GERD symptoms than men. […] However, men are at greater risk than women for erosive esophagitis. […] Advancing age has been inconsistently associated with an increased risk for GERD symptoms.
  • #27 Gastroesophageal Reflux Disease: Practice Essentials, Background, Anatomy
    https://emedicine.medscape.com/article/176595-overview
    No sexual predilection exists: GERD is as common in men as in women. However, the male-to-female incidence ratio for esophagitis is 2:1-3:1. The male-to-female incidence ratio for Barrett esophagus is 10:1. White males are at a greater risk for Barrett esophagus and adenocarcinoma than other populations. […] GERD occurs in all age groups. The prevalence of GERD increases in people older than 40 years.
  • #28 Gastroesophageal Reflux Disease (GERD) | Treatment & Management | Point of Care
    https://www.statpearls.com/point-of-care/28304
    The incidence of reflux esophagitis is greatest in individuals aged 60 to 70 and slightly decreases thereafter. Similar to its prevalence in adults, GERD is also increasingly observed in the pediatric population. Nelson et al reported an incidence of GERD ranging from 12% to 50% in children aged 0 to 18 between 2000 and 2005. […] The prevalence of GERD increases throughout pregnancy, affecting 20% to 30% of women in the first trimester, 40% to 45% in the second trimester, and 60% in the third trimester. […] The association of GERD with overweight patients has an odds ratio of 1.33 and 95% confidence intervals of 1.07 to 1.64; the association with obese individuals has an odds ratio of 1.70 and a 95% confidence interval of 1.36 to 2.12. […] Several medications have been associated with symptoms of GERD, including drugs that modulate the lower esophageal sphincter pressure, including nitrates, calcium channel blocker agents, anticholinergics, -adrenergic agonists, theophylline, and morphine.
  • #29 Presentation and Epidemiology of Gastroesophageal Reflux Disease
    https://pmc.ncbi.nlm.nih.gov/articles/PMC5797499/
    In 3 population-based studies of patients agreeing to undergo endoscopy regardless of symptoms, the prevalence of erosive esophagitis ranged from 6.4% in China to 15.5% in Sweden. […] Among individuals without symptoms of GERD, the prevalence of erosive esophagitis ranged from 6.1% in China to 9.5% in Sweden. […] Erosive esophagitis may frequently be a transient phenomenon. […] There are a number of well-recognized risk factors for GERD and its complications. […] In North America and in Europe, there is no association between sex and symptoms of GERD, but in South America and in the Middle East, women are approximately 40% more likely to report GERD symptoms than men. […] However, men are at greater risk than women for erosive esophagitis. […] Advancing age has been inconsistently associated with an increased risk for GERD symptoms.
  • #30 Presentation and Epidemiology of Gastroesophageal Reflux Disease
    https://pmc.ncbi.nlm.nih.gov/articles/PMC5797499/
    However, advancing age is more strongly associated with complications of GERD. […] In the US, there appears to be similar prevalence of GERD symptoms among different races. […] However, whites are at greater risk for erosive esophagitis, strictures, Barretts esophagus, and esophageal adenocarcinoma.
  • #31 Presentation and Epidemiology of Gastroesophageal Reflux Disease
    https://pmc.ncbi.nlm.nih.gov/articles/PMC5797499/
    In 3 population-based studies of patients agreeing to undergo endoscopy regardless of symptoms, the prevalence of erosive esophagitis ranged from 6.4% in China to 15.5% in Sweden. […] Among individuals without symptoms of GERD, the prevalence of erosive esophagitis ranged from 6.1% in China to 9.5% in Sweden. […] Erosive esophagitis may frequently be a transient phenomenon. […] There are a number of well-recognized risk factors for GERD and its complications. […] In North America and in Europe, there is no association between sex and symptoms of GERD, but in South America and in the Middle East, women are approximately 40% more likely to report GERD symptoms than men. […] However, men are at greater risk than women for erosive esophagitis. […] Advancing age has been inconsistently associated with an increased risk for GERD symptoms.
  • #32 Presentation and Epidemiology of Gastroesophageal Reflux Disease
    https://pmc.ncbi.nlm.nih.gov/articles/PMC5797499/
    In 3 population-based studies of patients agreeing to undergo endoscopy regardless of symptoms, the prevalence of erosive esophagitis ranged from 6.4% in China to 15.5% in Sweden. […] Among individuals without symptoms of GERD, the prevalence of erosive esophagitis ranged from 6.1% in China to 9.5% in Sweden. […] Erosive esophagitis may frequently be a transient phenomenon. […] There are a number of well-recognized risk factors for GERD and its complications. […] In North America and in Europe, there is no association between sex and symptoms of GERD, but in South America and in the Middle East, women are approximately 40% more likely to report GERD symptoms than men. […] However, men are at greater risk than women for erosive esophagitis. […] Advancing age has been inconsistently associated with an increased risk for GERD symptoms.
  • #33 Diagnostic and therapeutic management in gastroesophageal reflux disease: consensus of the Polish Society of Gastroenterology – Polish Archives of Internal Medicine
    https://www.mp.pl/paim/issue/article/16196/
    GERD prevalence is estimated at approximately 20%, based on the occurrence of heartburn and / or regurgitation 1-2 times a week. […] The prevalence of GERD is estimated at 8.8%25.9% in Europe, 2.5%7.8% in Asia, 8.7%33.1% in the Middle East, 11.6% in Australia, and 23% in South Africa. […] About 2540% of American adults report heartburn at least once a month, and about 7%10% of patients experience heartburn every day. […] In Poland, among 850 people aged 21-76, GERD symptoms were reported by 36% of the respondents. […] GERD has a negative impact on the patients quality of life. […] Reduced productivity and physical activity are especially reported by patients with frequent symptoms. […] GERD is equally common among men and women but complications are more common in men: erosive esophagitis (about 2 times more often), Barretts esophagus (BE) (about 10 times), and esophageal adenocarcinoma (about 8 times).
  • #34 Reflux Esophagitis Pathology: Definition, Epidemiology, Etiology
    https://emedicine.medscape.com/article/1610393-overview
    A Swedish population-based, cross-sectional study compared the prevalence of gastroesophageal reflux symptoms among English and Swedish populations and reported a higher prevalence of reflux symptoms occurring at least twice weekly in English populations compared with Swedish populations. […] With regard to sex-related differences, some studies report no sex predilection. Other studies indicate that males are more likely to develop severe forms of esophagitis and complications such as Barrett esophagus and esophageal adenocarcinoma. Conversely, females are more frequently affected by nonerosive reflux disease (NERD) and symptomatic GERD. The prevalence of reflux esophagitis increases with age, particularly in females after their 50s. […] As noted in adults, there is an increasing trend of GERD in the pediatric population too. Nelson et al reported an increased incidence of GERD that ranged from 12% to 50% in children aged 0-18 years between 2000 and 2005.
  • #35 Self-Assessment Questions – Course #94902: Gastroesophageal Reflux Disease in Adults – NetCE
    https://www.netce.com/studypoints.php?courseid=2881&printable=yes&page=printquestions
    Differences in GERD symptom expression have been suggested, with women more likely to have heartburn, regurgitation, belching, and extraesophageal symptoms than men. […] This suggests differences in upper GI response to reflux exposure, with greater sensitivity and symptoms in women despite less noxious acid exposure. […] However, men are more likely to develop pathologic changes of the esophagus. […] In patients who meet the criteria for GERD, symptoms can impose a serious negative burden on quality of life. […] Disruptive GERD (more than once weekly symptoms) increases patient time off from work and decreases work productivity. […] These patients often have sleep impairment and decreases in physical functioning compared with patients with infrequent symptoms. […] Nocturnal GERD has a greater negative impact on quality of life compared with daytime symptoms. […] One nationwide survey of 1,000 adults with heartburn at least once a week found that 79% reported nocturnal heartburn. […] The prevalence of GERD symptoms has increased in the past few decades.
  • #36 Presentation and Epidemiology of Gastroesophageal Reflux Disease
    https://pmc.ncbi.nlm.nih.gov/articles/PMC5797499/
    However, advancing age is more strongly associated with complications of GERD. […] In the US, there appears to be similar prevalence of GERD symptoms among different races. […] However, whites are at greater risk for erosive esophagitis, strictures, Barretts esophagus, and esophageal adenocarcinoma.
  • #37 Presentation and Epidemiology of Gastroesophageal Reflux Disease
    https://pmc.ncbi.nlm.nih.gov/articles/PMC5797499/
    However, advancing age is more strongly associated with complications of GERD. […] In the US, there appears to be similar prevalence of GERD symptoms among different races. […] However, whites are at greater risk for erosive esophagitis, strictures, Barretts esophagus, and esophageal adenocarcinoma.
  • #38 Gastroesophageal Reflux Disease: Practice Essentials, Background, Anatomy
    https://emedicine.medscape.com/article/176595-overview
    No sexual predilection exists: GERD is as common in men as in women. However, the male-to-female incidence ratio for esophagitis is 2:1-3:1. The male-to-female incidence ratio for Barrett esophagus is 10:1. White males are at a greater risk for Barrett esophagus and adenocarcinoma than other populations. […] GERD occurs in all age groups. The prevalence of GERD increases in people older than 40 years.
  • #39 Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis | Scientific Reports
    https://www.nature.com/articles/s41598-020-62795-1
    Stratified pooled prevalence of GORD by BMI showed an increase in GORD prevalence as BMI increased. […] The prevalence of GORD was highest in subjects with low education level (16.78%), followed by those with medium education level (11.52%), and the lowest GORD prevalence was seen in those with a high education level (8.98%). […] When the pooled prevalence of GORD was stratified according to marriage status, the highest prevalence of GORD was found in divorced/separated/widowed individuals (22.95%) followed by married individuals (15.98%), and the lowest GORD prevalence was seen in single individuals (12.85%). […] The pooled prevalence of GORD according to NSAIDs/aspirin use showed a significantly greater prevalence of GORD in subjects using NSAIDs/aspirin (24.47%) compared with those who do not (17.34%).
  • #40 Gastroesophageal Reflux Disease (GERD) | Treatment & Management | Point of Care
    https://www.statpearls.com/point-of-care/28304
    The incidence of reflux esophagitis is greatest in individuals aged 60 to 70 and slightly decreases thereafter. Similar to its prevalence in adults, GERD is also increasingly observed in the pediatric population. Nelson et al reported an incidence of GERD ranging from 12% to 50% in children aged 0 to 18 between 2000 and 2005. […] The prevalence of GERD increases throughout pregnancy, affecting 20% to 30% of women in the first trimester, 40% to 45% in the second trimester, and 60% in the third trimester. […] The association of GERD with overweight patients has an odds ratio of 1.33 and 95% confidence intervals of 1.07 to 1.64; the association with obese individuals has an odds ratio of 1.70 and a 95% confidence interval of 1.36 to 2.12. […] Several medications have been associated with symptoms of GERD, including drugs that modulate the lower esophageal sphincter pressure, including nitrates, calcium channel blocker agents, anticholinergics, -adrenergic agonists, theophylline, and morphine.
  • #41 Epidemiology, Causes, and Management of Gastro-esophageal Reflux Disease: A Systematic Review
    https://pmc.ncbi.nlm.nih.gov/articles/PMC10658748/
    Our comprehensive systematic review aimed to examine gastroesophageal reflux disease (GERD), a disorder that occurs when stomach contents flow back into the esophagus. […] Millions of individuals worldwide suffer from GERD, a common clinical condition. […] GERD is a common gastrointestinal disorder, affecting around 20% of adults in Western cultures. […] The prevalence in the US ranges from 18.1% to 27.8%, with a slightly higher rate in men. […] GERD is a frequent digestive illness around the world, with a prevalence range of 18.1%-27.8% in North America. […] In the US, the rate of GERD symptoms is over 20%, with 110,000 hospitalizations each year. […] With regional fluctuation, the overall frequency of GERD symptoms is roughly 13%. […] The prevalence range in the US is 6%-30%, with variation depending on the questionnaire utilized. […] GERD is a prevalent disease in the Western world, affecting 10%-20% of the population. […] In the US, the rising obesity epidemic is correlated with an increased prevalence of GERD.
  • #42 Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis | Scientific Reports
    https://www.nature.com/articles/s41598-020-62795-1
    The area of domicile also had a significant effect on the prevalence of GORD. The pooled prevalence of GORD in subjects living in an urban area was the highest (13.43%) followed by subjects living in a rural area (11.70%). […] The pooled prevalence of GORD according to smoking habits showed that subjects who currently smoke had a higher prevalence of GORD (18.40%) compared with ex-smokers (16.83%) and non-smokers (15.55%). […] Subjects with a low income had a significantly higher prevalence of GORD (11.69%) than those with a medium income (8.42%) and those with a high income (7.68%). […] The effect of dietary intake of certain food and drinks (spicy food, sweet food, meat/fish, carbonated drinks, fatty food, fried food, and coffee/tea) on the pooled prevalence of GORD was also investigated.
  • #43 Prevalence of gastro-oesophageal reflux disease, and its associated risk factors among medical students: a nation-based cross-sectional study | BMC Gastroenterology | Full Text
    https://bmcgastroenterol.biomedcentral.com/articles/10.1186/s12876-023-02899-w
    This study revealed that GERD family history is significantly associated with GERD and is an independent predictor of it. […] In the current study, 23.7% of medical students experienced high levels of perceived stress, and participants who experienced high levels of perceived stress were more likely to develop GERD. […] Stress, smoking, and family history were independent predictors of GERD.
  • #44 Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis | Scientific Reports
    https://www.nature.com/articles/s41598-020-62795-1
    The aim of the current review was to search the literature systematically using PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 2009 guidelines and estimate the global prevalence of GORD, the prevalence of GORD according to geographical location and to identify risk factors associated with an increased risk of the condition. […] The pooled prevalence of GORD in females (17.17%) was moderately higher than in males (15.69%). […] The pooled prevalence of GORD according to age groups displayed an increase with increasing age between the age groups of 18-34 years (8.70%) and 35-59 years (14.53%). […] The pooled prevalence of GORD according to alcohol intake showed a similar GORD prevalence in those who do not drink alcohol or have a low intake of alcohol (15.95%) compared with those who have a moderate to high intake of alcohol (15.56%).
  • #45 A narrative review of the prevalence of gastroesophageal reflux disease (GERD) – Boulton – Annals of Esophagus
    https://aoe.amegroups.org/article/view/6041/html
    Many papers have reported a trend in GERD symptoms in obese individuals indicating a link between obesity and GERD. […] An increased pressure around the abdomen also makes pregnant women at risk of GERD symptoms. […] Certain foods and drinks are associated with the incidence of reflux and studies have shown that consuming large amounts of fatty foods and chocolate cause episodes of reflux. […] Many categories of drugs are associated with increasing GERD symptoms, by causing mucosal damage lowering sphincter pressure or by affecting esophagogastric motility.
  • #46 Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis | Scientific Reports
    https://www.nature.com/articles/s41598-020-62795-1
    Subjects with a moderate/high intake of carbonated drinks had a higher pooled prevalence of GORD than those with low/none intake (18.60% vs 14.54%, respectively). […] Pooling prevalence of GORD according to intake of coffee/tea revealed a higher GORD prevalence in subjects with a moderate/high intake of coffee/tea (21.02%) than those with a low/none intake (16.92%). […] This comprehensive systematic review has demonstrated the significant global burden of GORD with approximately 1.03 billion individuals suffering from the condition globally. […] It has also confirmed substantial variations in the pooled prevalence of GORD between regions and countries.
  • #47 Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis | Scientific Reports
    https://www.nature.com/articles/s41598-020-62795-1
    Subjects with a moderate/high intake of carbonated drinks had a higher pooled prevalence of GORD than those with low/none intake (18.60% vs 14.54%, respectively). […] Pooling prevalence of GORD according to intake of coffee/tea revealed a higher GORD prevalence in subjects with a moderate/high intake of coffee/tea (21.02%) than those with a low/none intake (16.92%). […] This comprehensive systematic review has demonstrated the significant global burden of GORD with approximately 1.03 billion individuals suffering from the condition globally. […] It has also confirmed substantial variations in the pooled prevalence of GORD between regions and countries.
  • #48 Prevalence of gastro-oesophageal reflux disease, and its associated risk factors among medical students: a nation-based cross-sectional study | BMC Gastroenterology | Full Text
    https://bmcgastroenterol.biomedcentral.com/articles/10.1186/s12876-023-02899-w
    This study revealed that GERD family history is significantly associated with GERD and is an independent predictor of it. […] In the current study, 23.7% of medical students experienced high levels of perceived stress, and participants who experienced high levels of perceived stress were more likely to develop GERD. […] Stress, smoking, and family history were independent predictors of GERD.
  • #49 Prevalence of gastro-oesophageal reflux disease, and its associated risk factors among medical students: a nation-based cross-sectional study | BMC Gastroenterology | Full Text
    https://bmcgastroenterol.biomedcentral.com/articles/10.1186/s12876-023-02899-w
    This study revealed that GERD family history is significantly associated with GERD and is an independent predictor of it. […] In the current study, 23.7% of medical students experienced high levels of perceived stress, and participants who experienced high levels of perceived stress were more likely to develop GERD. […] Stress, smoking, and family history were independent predictors of GERD.
  • #50 Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis | Scientific Reports
    https://www.nature.com/articles/s41598-020-62795-1
    Stratified pooled prevalence of GORD by BMI showed an increase in GORD prevalence as BMI increased. […] The prevalence of GORD was highest in subjects with low education level (16.78%), followed by those with medium education level (11.52%), and the lowest GORD prevalence was seen in those with a high education level (8.98%). […] When the pooled prevalence of GORD was stratified according to marriage status, the highest prevalence of GORD was found in divorced/separated/widowed individuals (22.95%) followed by married individuals (15.98%), and the lowest GORD prevalence was seen in single individuals (12.85%). […] The pooled prevalence of GORD according to NSAIDs/aspirin use showed a significantly greater prevalence of GORD in subjects using NSAIDs/aspirin (24.47%) compared with those who do not (17.34%).
  • #51 Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis | Scientific Reports
    https://www.nature.com/articles/s41598-020-62795-1
    The area of domicile also had a significant effect on the prevalence of GORD. The pooled prevalence of GORD in subjects living in an urban area was the highest (13.43%) followed by subjects living in a rural area (11.70%). […] The pooled prevalence of GORD according to smoking habits showed that subjects who currently smoke had a higher prevalence of GORD (18.40%) compared with ex-smokers (16.83%) and non-smokers (15.55%). […] Subjects with a low income had a significantly higher prevalence of GORD (11.69%) than those with a medium income (8.42%) and those with a high income (7.68%). […] The effect of dietary intake of certain food and drinks (spicy food, sweet food, meat/fish, carbonated drinks, fatty food, fried food, and coffee/tea) on the pooled prevalence of GORD was also investigated.
  • #52 Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis | Scientific Reports
    https://www.nature.com/articles/s41598-020-62795-1
    Stratified pooled prevalence of GORD by BMI showed an increase in GORD prevalence as BMI increased. […] The prevalence of GORD was highest in subjects with low education level (16.78%), followed by those with medium education level (11.52%), and the lowest GORD prevalence was seen in those with a high education level (8.98%). […] When the pooled prevalence of GORD was stratified according to marriage status, the highest prevalence of GORD was found in divorced/separated/widowed individuals (22.95%) followed by married individuals (15.98%), and the lowest GORD prevalence was seen in single individuals (12.85%). […] The pooled prevalence of GORD according to NSAIDs/aspirin use showed a significantly greater prevalence of GORD in subjects using NSAIDs/aspirin (24.47%) compared with those who do not (17.34%).
  • #53 Gastroesophageal Reflux Disease (GERD) | Treatment & Management | Point of Care
    https://www.statpearls.com/point-of-care/28304
    The incidence of reflux esophagitis is greatest in individuals aged 60 to 70 and slightly decreases thereafter. Similar to its prevalence in adults, GERD is also increasingly observed in the pediatric population. Nelson et al reported an incidence of GERD ranging from 12% to 50% in children aged 0 to 18 between 2000 and 2005. […] The prevalence of GERD increases throughout pregnancy, affecting 20% to 30% of women in the first trimester, 40% to 45% in the second trimester, and 60% in the third trimester. […] The association of GERD with overweight patients has an odds ratio of 1.33 and 95% confidence intervals of 1.07 to 1.64; the association with obese individuals has an odds ratio of 1.70 and a 95% confidence interval of 1.36 to 2.12. […] Several medications have been associated with symptoms of GERD, including drugs that modulate the lower esophageal sphincter pressure, including nitrates, calcium channel blocker agents, anticholinergics, -adrenergic agonists, theophylline, and morphine.
  • #54 A narrative review of the prevalence of gastroesophageal reflux disease (GERD) – Boulton – Annals of Esophagus
    https://aoe.amegroups.org/article/view/6041/html
    Many papers have reported a trend in GERD symptoms in obese individuals indicating a link between obesity and GERD. […] An increased pressure around the abdomen also makes pregnant women at risk of GERD symptoms. […] Certain foods and drinks are associated with the incidence of reflux and studies have shown that consuming large amounts of fatty foods and chocolate cause episodes of reflux. […] Many categories of drugs are associated with increasing GERD symptoms, by causing mucosal damage lowering sphincter pressure or by affecting esophagogastric motility.
  • #55 Gastroesophageal Reflux Disease (GERD) | Treatment & Management | Point of Care
    https://www.statpearls.com/point-of-care/28304
    The incidence of reflux esophagitis is greatest in individuals aged 60 to 70 and slightly decreases thereafter. Similar to its prevalence in adults, GERD is also increasingly observed in the pediatric population. Nelson et al reported an incidence of GERD ranging from 12% to 50% in children aged 0 to 18 between 2000 and 2005. […] The prevalence of GERD increases throughout pregnancy, affecting 20% to 30% of women in the first trimester, 40% to 45% in the second trimester, and 60% in the third trimester. […] The association of GERD with overweight patients has an odds ratio of 1.33 and 95% confidence intervals of 1.07 to 1.64; the association with obese individuals has an odds ratio of 1.70 and a 95% confidence interval of 1.36 to 2.12. […] Several medications have been associated with symptoms of GERD, including drugs that modulate the lower esophageal sphincter pressure, including nitrates, calcium channel blocker agents, anticholinergics, -adrenergic agonists, theophylline, and morphine.
  • #56 Reflux Esophagitis Pathology: Definition, Epidemiology, Etiology
    https://emedicine.medscape.com/article/1610393-overview
    A Swedish population-based, cross-sectional study compared the prevalence of gastroesophageal reflux symptoms among English and Swedish populations and reported a higher prevalence of reflux symptoms occurring at least twice weekly in English populations compared with Swedish populations. […] With regard to sex-related differences, some studies report no sex predilection. Other studies indicate that males are more likely to develop severe forms of esophagitis and complications such as Barrett esophagus and esophageal adenocarcinoma. Conversely, females are more frequently affected by nonerosive reflux disease (NERD) and symptomatic GERD. The prevalence of reflux esophagitis increases with age, particularly in females after their 50s. […] As noted in adults, there is an increasing trend of GERD in the pediatric population too. Nelson et al reported an increased incidence of GERD that ranged from 12% to 50% in children aged 0-18 years between 2000 and 2005.
  • #57 Prevalence of gastro-oesophageal reflux disease, and its associated risk factors among medical students: a nation-based cross-sectional study | BMC Gastroenterology | Full Text
    https://bmcgastroenterol.biomedcentral.com/articles/10.1186/s12876-023-02899-w
    Gastroesophageal reflux disease (GERD) is a common digestive problem in adults particularly medical students, who are one of the most vulnerable groups. […] Overall, 17.1% of participants reported symptoms of GERD. […] GERD is a frequent condition among Egyptian medical students, affecting around one-fifth of them. […] Gastroesophageal reflux disease (GERD) is predicted to impact 13.98% of the adult population worldwide. […] Many factors put medical students at increased risk for gastroesophageal reflux disease (GERD), including an unhealthy diet, and excessive coffee intake. […] According to this study, it was found that 17.1% of medical students in Egypt had GERD, which is regarded as relatively high. […] The prevalence of GERD varies greatly over the world, ranging from 2.5 to 7.8% in East Asia, 8.7-33.1% in the Middle East, 8.8-25.9% in Europe, 18.1-27.8% in North America, 23.0% in South America, and 11.6% in Australia.
  • #58 Gastroesophageal Reflux Disease Among Undergraduate Medical Students i | IJGM
    https://www.dovepress.com/gastroesophageal-reflux-disease-among-undergraduate-medical-students-i-peer-reviewed-fulltext-article-IJGM
    Gastroesophageal reflux disease (GERD) is a prevalent gastrointestinal condition that has a detrimental impact on ones quality of life because of acid reflux causing damage to the esophagus. […] This study investigates the prevalence of GERD among medical students in Egypt and explores associated risk factors. […] The prevalence of GERD was found to be 28.4%, with heartburn and regurgitation being the most prevalent symptoms among participants. […] Univariate and multivariate logistic regression revealed family history of GERD and stress after medical school enrollment as significant predictors of GERD symptoms (p=0.043 and p=0.044, respectively). […] GERD has become increasingly common among medical students in Egypt. […] To address this, it is essential to implement counseling programs and raise awareness as initial steps toward reducing GERD prevalence.
  • #59 Prevalence and Risk Factors of Gastroesophageal Reflux Disease in Patients with Type 2 Diabetes Mellitus
    https://www.e-dmj.org/journal/view.php?doi=10.4093/dmj.2016.40.4.297
    The prevalence of gastroesophageal reflux disease (GERD) in Korea appears to be increasing. […] Some studies have shown that T2DM is a risk factor for symptomatic GERD. […] The aim of this study was to analyze the prevalence and risk factors (including autonomic neuropathy) of GERD in patients with T2DM. […] The prevalence of GERD (32.6% vs. 35.9%, P=0.266) and GERD symptoms (58.8% vs. 59.2%, P=0.503) was not significantly different between T2DM patients and controls. […] The prevalence of GERD in patients with T2DM showed no difference from that of controls. […] GERD was also not associated with peripheral and cardiovascular autonomic neuropathy, age, or duration of DM in patients with T2DM. […] The prevalence of gastroesophageal reflux disease (GERD) is reported as 10% to 20% in Western countries, whereas Asian countries have a lower prevalence.
  • #60 Prevalence and Risk Factors of Gastroesophageal Reflux Disease in Patients with Type 2 Diabetes Mellitus
    https://www.e-dmj.org/journal/view.php?doi=10.4093/dmj.2016.40.4.297
    Recent studies have shown that the prevalence of GERD is increasing in Asia. […] A Korean study reported a prevalence of 18% for erosive esophagitis among patients with diabetes mellitus (DM) who underwent esophagogastroduodenoscopy (EGD) due to various GI symptoms. […] Some studies have shown that T2DM is a risk factor for symptomatic GERD, and a higher prevalence (28%) of abnormal GE reflux appeared among asymptomatic diabetic patients than among the general population. […] However, in the present study, the occurrence rate of GERD of 32.6% in the T2DM group and 35.9% in the control group indicated no significant correlation between the presence of diabetes and GERD. […] Typical GERD symptoms showed a prevalence of 58.8% in the T2DM group and 59.2% in the control group, again indicating no correlation. […] The present study confirmed that the presence of cardiovascular autonomic neuropathy and peripheral neuropathy in T2DM patients with GERD and T2DM patients without GERD did not affect the prevalence of GERD.
  • #61 Epidemiology of gastroesophageal reflux disease | WHO FCTC
    https://portal-uat.who.int/fctcapps/fctcapps/fctc/kh/wts/wts-database/epidemiology-gastroesophageal-reflux-disease
    The prevalence of gastroesophageal reflux disease (GERD) symptoms increased approximately 50% until the mid-1990s, when it plateaued. […] The incidence of complications related to GERD including hospitalization, esophageal strictures, esophageal adenocarcinoma, and mortality also increased during that time period, but the increase in esophageal adenocarcinoma has since slowed, and the incidence of strictures has decreased since the mid-1990s. […] GERD is responsible for the greatest direct costs in the United States of any gastrointestinal disease, and most of those expenditures are for pharmacotherapy. […] Risk factors for GERD include obesity, poor diet, lack of physical activity, consumption of tobacco and alcohol, and respiratory diseases.
  • #62 Healthcare Resource Utilization and Costs Among Patients With Gastroesophageal Reflux Disease, Barrett’s Esophagus, and Barrett’s Esophagus-Related Neoplasia in the United States | Published in Journal of Health Economics and Outcomes Research
    https://jheor.org/article/68191-healthcare-resource-utilization-and-costs-among-patients-with-gastroesophageal-reflux-disease-barrett-s-esophagus-and-barrett-s-esophagus-related-ne
    Gastroesophageal reflux disease (GERD) is a risk factor for Barretts esophagus (BE) and BE-related neoplasia (BERN). […] Approximately 25% to 35% of adults in the United States have GERD and, of these patients, 10% to 20% develop BE with a prevalence of 1.6% in the general population. […] Barretts esophagus remains the only known precursor to EAC, one of the most lethal cancers in the United States with a median survival time of 15 months. […] In 2018, the annual healthcare expenditures for esophageal disorders exceeded $12 billion in the United States. […] As the incidence of BE and EAC continues to increase over time, the associated economic burden is likely to increase, necessitating an up-to-date evaluation. […] The aim of this study was to evaluate healthcare resource utilization (HRU) and direct healthcare costs associated with GERD, BE, and BERN.
  • #63 The Prevalence and Impact of Gastroesophageal Reflux Disease – About GERD
    https://aboutgerd.org/what-is/prevalence/
    Over the past several years, healthcare professionals have become increasingly interested in gastroesophageal reflux disease (GERD) because of its prevalence and impact on the community. […] Studies suggest that approximately one-third of the population has GERD, according to the American Gastroenterological Association. […] A review study published in the journal Gut reports the following range of GERD prevalence estimates in global populations: 18 to 28% North America 9 to 26% Europe 3 to 8% East Asia 9 to 33% Middle East 12% Australia 23% South America. […] According to a recent study on the burden of chronic gastrointestinal disorders, GERD was found to be the most expensive, with direct and indirect costs totaling $10 billion per year.
  • #64 The Clinical Relevance of Gastroesophageal Reflux Disease and Laryngopharyngeal Reflux in Clinical Practice | IntechOpen
    https://www.intechopen.com/chapters/61811
    Gastroesophageal reflux disease (GERD) emerges when defense mechanisms fail, leading to the reflux of gastric contents into the esophagus. The prevalence of GERD in the primary care setting seems to be even more evident when one considers that, in the United States, 4.6 million office encounters annually are primarily for GERD, whereas 9.1 million encounters include GERD in the top 3 diagnoses for the encounter. GERD constitutes also the most frequently first-listed gastrointestinal diagnosis in ambulatory care visits. […] In population-based studies, 19.8% of North Americans complain of GERD symptoms, including heartburn and regurgitation, at least weekly. Likewise, in the late 1990s, GERD accounted for $9.3 to $12.1 billion in direct annual healthcare costs in the United States, higher than any other digestive disease. Consequently, acid-suppressive agents are still the leading pharmaceutical expenditure in the United States.
  • #65 The Clinical Relevance of Gastroesophageal Reflux Disease and Laryngopharyngeal Reflux in Clinical Practice | IntechOpen
    https://www.intechopen.com/chapters/61811
    Gastroesophageal reflux disease (GERD) emerges when defense mechanisms fail, leading to the reflux of gastric contents into the esophagus. The prevalence of GERD in the primary care setting seems to be even more evident when one considers that, in the United States, 4.6 million office encounters annually are primarily for GERD, whereas 9.1 million encounters include GERD in the top 3 diagnoses for the encounter. GERD constitutes also the most frequently first-listed gastrointestinal diagnosis in ambulatory care visits. […] In population-based studies, 19.8% of North Americans complain of GERD symptoms, including heartburn and regurgitation, at least weekly. Likewise, in the late 1990s, GERD accounted for $9.3 to $12.1 billion in direct annual healthcare costs in the United States, higher than any other digestive disease. Consequently, acid-suppressive agents are still the leading pharmaceutical expenditure in the United States.
  • #66 The Clinical Relevance of Gastroesophageal Reflux Disease and Laryngopharyngeal Reflux in Clinical Practice | IntechOpen
    https://www.intechopen.com/chapters/61811
    Estimates of the economic burden of extraesophageal reflux have shown that expenditures for extraesophageal manifestations of reflux could surpass $50 billion, 86% of which could be attributable to pharmaceutical costs. […] Epidemiological studies have shown that the prevalence of laryngopharyngeal reflux (LPR) may be extremely high, that it has certain characteristics of an outbreak and that it is one of the most common causes of patient visits to their family medicine physicians, but also to otolaryngologists, gastroenterologists, pediatricians, pulmonologists, allergists, and psychiatrists. […] The Montreal Classification gave the most recent consensus definition of GERD. This document defines GERD as heartburn symptoms or complications resulting from the reflux of gastric contents into the esophagus, up to the oral cavity, and lungs.
  • #67 Diagnostic and therapeutic management in gastroesophageal reflux disease: consensus of the Polish Society of Gastroenterology – Polish Archives of Internal Medicine
    https://www.mp.pl/paim/issue/article/16196/
    GERD prevalence is estimated at approximately 20%, based on the occurrence of heartburn and / or regurgitation 1-2 times a week. […] The prevalence of GERD is estimated at 8.8%25.9% in Europe, 2.5%7.8% in Asia, 8.7%33.1% in the Middle East, 11.6% in Australia, and 23% in South Africa. […] About 2540% of American adults report heartburn at least once a month, and about 7%10% of patients experience heartburn every day. […] In Poland, among 850 people aged 21-76, GERD symptoms were reported by 36% of the respondents. […] GERD has a negative impact on the patients quality of life. […] Reduced productivity and physical activity are especially reported by patients with frequent symptoms. […] GERD is equally common among men and women but complications are more common in men: erosive esophagitis (about 2 times more often), Barretts esophagus (BE) (about 10 times), and esophageal adenocarcinoma (about 8 times).
  • #68 Diagnostic and therapeutic management in gastroesophageal reflux disease: consensus of the Polish Society of Gastroenterology – Polish Archives of Internal Medicine
    https://www.mp.pl/paim/issue/article/16196/
    GERD prevalence is estimated at approximately 20%, based on the occurrence of heartburn and / or regurgitation 1-2 times a week. […] The prevalence of GERD is estimated at 8.8%25.9% in Europe, 2.5%7.8% in Asia, 8.7%33.1% in the Middle East, 11.6% in Australia, and 23% in South Africa. […] About 2540% of American adults report heartburn at least once a month, and about 7%10% of patients experience heartburn every day. […] In Poland, among 850 people aged 21-76, GERD symptoms were reported by 36% of the respondents. […] GERD has a negative impact on the patients quality of life. […] Reduced productivity and physical activity are especially reported by patients with frequent symptoms. […] GERD is equally common among men and women but complications are more common in men: erosive esophagitis (about 2 times more often), Barretts esophagus (BE) (about 10 times), and esophageal adenocarcinoma (about 8 times).
  • #69 Self-Assessment Questions – Course #94902: Gastroesophageal Reflux Disease in Adults – NetCE
    https://www.netce.com/studypoints.php?courseid=2881&printable=yes&page=printquestions
    Differences in GERD symptom expression have been suggested, with women more likely to have heartburn, regurgitation, belching, and extraesophageal symptoms than men. […] This suggests differences in upper GI response to reflux exposure, with greater sensitivity and symptoms in women despite less noxious acid exposure. […] However, men are more likely to develop pathologic changes of the esophagus. […] In patients who meet the criteria for GERD, symptoms can impose a serious negative burden on quality of life. […] Disruptive GERD (more than once weekly symptoms) increases patient time off from work and decreases work productivity. […] These patients often have sleep impairment and decreases in physical functioning compared with patients with infrequent symptoms. […] Nocturnal GERD has a greater negative impact on quality of life compared with daytime symptoms. […] One nationwide survey of 1,000 adults with heartburn at least once a week found that 79% reported nocturnal heartburn. […] The prevalence of GERD symptoms has increased in the past few decades.
  • #70 Self-Assessment Questions – Course #94902: Gastroesophageal Reflux Disease in Adults – NetCE
    https://www.netce.com/studypoints.php?courseid=2881&printable=yes&page=printquestions
    Differences in GERD symptom expression have been suggested, with women more likely to have heartburn, regurgitation, belching, and extraesophageal symptoms than men. […] This suggests differences in upper GI response to reflux exposure, with greater sensitivity and symptoms in women despite less noxious acid exposure. […] However, men are more likely to develop pathologic changes of the esophagus. […] In patients who meet the criteria for GERD, symptoms can impose a serious negative burden on quality of life. […] Disruptive GERD (more than once weekly symptoms) increases patient time off from work and decreases work productivity. […] These patients often have sleep impairment and decreases in physical functioning compared with patients with infrequent symptoms. […] Nocturnal GERD has a greater negative impact on quality of life compared with daytime symptoms. […] One nationwide survey of 1,000 adults with heartburn at least once a week found that 79% reported nocturnal heartburn. […] The prevalence of GERD symptoms has increased in the past few decades.
  • #71 Self-Assessment Questions – Course #94902: Gastroesophageal Reflux Disease in Adults – NetCE
    https://www.netce.com/studypoints.php?courseid=2881&printable=yes&page=printquestions
    Differences in GERD symptom expression have been suggested, with women more likely to have heartburn, regurgitation, belching, and extraesophageal symptoms than men. […] This suggests differences in upper GI response to reflux exposure, with greater sensitivity and symptoms in women despite less noxious acid exposure. […] However, men are more likely to develop pathologic changes of the esophagus. […] In patients who meet the criteria for GERD, symptoms can impose a serious negative burden on quality of life. […] Disruptive GERD (more than once weekly symptoms) increases patient time off from work and decreases work productivity. […] These patients often have sleep impairment and decreases in physical functioning compared with patients with infrequent symptoms. […] Nocturnal GERD has a greater negative impact on quality of life compared with daytime symptoms. […] One nationwide survey of 1,000 adults with heartburn at least once a week found that 79% reported nocturnal heartburn. […] The prevalence of GERD symptoms has increased in the past few decades.
  • #72 Self-Assessment Questions – Course #94902: Gastroesophageal Reflux Disease in Adults – NetCE
    https://www.netce.com/studypoints.php?courseid=2881&printable=yes&page=printquestions
    Differences in GERD symptom expression have been suggested, with women more likely to have heartburn, regurgitation, belching, and extraesophageal symptoms than men. […] This suggests differences in upper GI response to reflux exposure, with greater sensitivity and symptoms in women despite less noxious acid exposure. […] However, men are more likely to develop pathologic changes of the esophagus. […] In patients who meet the criteria for GERD, symptoms can impose a serious negative burden on quality of life. […] Disruptive GERD (more than once weekly symptoms) increases patient time off from work and decreases work productivity. […] These patients often have sleep impairment and decreases in physical functioning compared with patients with infrequent symptoms. […] Nocturnal GERD has a greater negative impact on quality of life compared with daytime symptoms. […] One nationwide survey of 1,000 adults with heartburn at least once a week found that 79% reported nocturnal heartburn. […] The prevalence of GERD symptoms has increased in the past few decades.
  • #73 Presentation and Epidemiology of Gastroesophageal Reflux Disease
    https://pmc.ncbi.nlm.nih.gov/articles/PMC5797499/
    In the US, estimates of the prevalence of GERD symptoms have ranged from 6% to 30%, with heterogeneity related to the particular questionnaire used, including the threshold frequency and duration of symptoms required to be classified as GERD. The prevalence of at least weekly GERD symptoms in the US is approximately 20%. […] Importantly, the prevalence of GERD symptoms in North America, Europe, and Southeast Asia has increased approximately 50% relative to the baseline prevalence in the early to middle 1990s, but has plateaued since then. […] There are approximately 110,000 hospital admissions annually in the US for GERD. […] The predominant complications of GERD include dysphagia (including from peptic strictures, Schatzkis rings), bleeding from erosive esophagitis, and esophageal adenocarcinoma.
  • #74 Presentation and Epidemiology of Gastroesophageal Reflux Disease
    https://pmc.ncbi.nlm.nih.gov/articles/PMC5797499/
    In 3 population-based studies of patients agreeing to undergo endoscopy regardless of symptoms, the prevalence of erosive esophagitis ranged from 6.4% in China to 15.5% in Sweden. […] Among individuals without symptoms of GERD, the prevalence of erosive esophagitis ranged from 6.1% in China to 9.5% in Sweden. […] Erosive esophagitis may frequently be a transient phenomenon. […] There are a number of well-recognized risk factors for GERD and its complications. […] In North America and in Europe, there is no association between sex and symptoms of GERD, but in South America and in the Middle East, women are approximately 40% more likely to report GERD symptoms than men. […] However, men are at greater risk than women for erosive esophagitis. […] Advancing age has been inconsistently associated with an increased risk for GERD symptoms.
  • #75 Presentation and Epidemiology of Gastroesophageal Reflux Disease
    https://pmc.ncbi.nlm.nih.gov/articles/PMC5797499/
    In 3 population-based studies of patients agreeing to undergo endoscopy regardless of symptoms, the prevalence of erosive esophagitis ranged from 6.4% in China to 15.5% in Sweden. […] Among individuals without symptoms of GERD, the prevalence of erosive esophagitis ranged from 6.1% in China to 9.5% in Sweden. […] Erosive esophagitis may frequently be a transient phenomenon. […] There are a number of well-recognized risk factors for GERD and its complications. […] In North America and in Europe, there is no association between sex and symptoms of GERD, but in South America and in the Middle East, women are approximately 40% more likely to report GERD symptoms than men. […] However, men are at greater risk than women for erosive esophagitis. […] Advancing age has been inconsistently associated with an increased risk for GERD symptoms.
  • #76 Diagnostic and therapeutic management in gastroesophageal reflux disease: consensus of the Polish Society of Gastroenterology – Polish Archives of Internal Medicine
    https://www.mp.pl/paim/issue/article/16196/
    Erosive esophagitis was found in 6.4% of patients in China and 15.5% of patients in Sweden in populational studies of patients undergoing endoscopy, regardless of the reported symptoms. […] A prospective study found erosions in the esophagus in 26% of patients with non-erosive reflux disease (NERD) after 2 years, while in another study, erosive esophagitis was found in a follow-up endoscopy after 5 years in 10% of patients. […] GERD is a risk factor for BE, which affects approximately 2% of the population and may progress to esophageal adenocarcinoma. […] GERD increases the risk of esophageal adenocarcinoma (odds ratio [OR], 7.7; 95% CI, 5.311.4), especially in patients with long-term GERD and severe or daily symptoms. […] The risk, however, is low and accounts for less than 0.001% annually. […] The risk of esophageal adenocarcinoma in patients with BE is clearly greater in those with at least low-grade epithelial dysplasia.
  • #77 Gastroesophageal reflux disease and heartburn Information | Mount Sinai – New York
    https://www.mountsinai.org/health-library/report/gastroesophageal-reflux-disease-and-heartburn
    Long-term use of PPIs has been linked to an increased risk of hip, wrist, and spine fractures. […] The hallmark symptoms of GERD may occur several times per day and include: Heartburn. A burning sensation in the chest and throat. […] Early diagnosis and treatment is best in order to avoid complications such as changes in the esophagus that can lead to cancer. […] The incidence of esophageal cancer is higher in people with Barrett esophagus. […] Only 10% of people with symptomatic GERD have Barrett esophagus. […] Periodic endoscopy is recommended for detecting cancer at an earlier stage in people who have been diagnosed with Barrett esophagus. […] The risks and benefits of long-term use of proton pump inhibitors: Expert review and best practice advice from the American Gastroenterological Association.
  • #78 Diagnostic and therapeutic management in gastroesophageal reflux disease: consensus of the Polish Society of Gastroenterology – Polish Archives of Internal Medicine
    https://www.mp.pl/paim/issue/article/16196/
    Erosive esophagitis was found in 6.4% of patients in China and 15.5% of patients in Sweden in populational studies of patients undergoing endoscopy, regardless of the reported symptoms. […] A prospective study found erosions in the esophagus in 26% of patients with non-erosive reflux disease (NERD) after 2 years, while in another study, erosive esophagitis was found in a follow-up endoscopy after 5 years in 10% of patients. […] GERD is a risk factor for BE, which affects approximately 2% of the population and may progress to esophageal adenocarcinoma. […] GERD increases the risk of esophageal adenocarcinoma (odds ratio [OR], 7.7; 95% CI, 5.311.4), especially in patients with long-term GERD and severe or daily symptoms. […] The risk, however, is low and accounts for less than 0.001% annually. […] The risk of esophageal adenocarcinoma in patients with BE is clearly greater in those with at least low-grade epithelial dysplasia.
  • #79 Diagnostic and therapeutic management in gastroesophageal reflux disease: consensus of the Polish Society of Gastroenterology – Polish Archives of Internal Medicine
    https://www.mp.pl/paim/issue/article/16196/
    Erosive esophagitis was found in 6.4% of patients in China and 15.5% of patients in Sweden in populational studies of patients undergoing endoscopy, regardless of the reported symptoms. […] A prospective study found erosions in the esophagus in 26% of patients with non-erosive reflux disease (NERD) after 2 years, while in another study, erosive esophagitis was found in a follow-up endoscopy after 5 years in 10% of patients. […] GERD is a risk factor for BE, which affects approximately 2% of the population and may progress to esophageal adenocarcinoma. […] GERD increases the risk of esophageal adenocarcinoma (odds ratio [OR], 7.7; 95% CI, 5.311.4), especially in patients with long-term GERD and severe or daily symptoms. […] The risk, however, is low and accounts for less than 0.001% annually. […] The risk of esophageal adenocarcinoma in patients with BE is clearly greater in those with at least low-grade epithelial dysplasia.
  • #80 Gastroesophageal reflux disease (GERD) – Symptoms and causes – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/gerd/symptoms-causes/syc-20361940
    Gastroesophageal reflux disease (GERD) happens when stomach acid flows back up into the esophagus and causes heartburn. It’s often called GERD for short. This backwash is known as acid reflux, and it can irritate the lining of the esophagus. […] GERD is caused by frequent acid reflux or reflux of nonacidic content from the stomach. […] Conditions that can increase the risk of GERD include obesity, bulging of the top of the stomach up above the diaphragm, known as a hiatal hernia, pregnancy, connective tissue disorders, such as scleroderma, and delayed stomach emptying. […] Over time, long-lasting inflammation in the esophagus can cause inflammation of the tissue in the esophagus, known as esophagitis. Stomach acid can break down tissue in the esophagus. This can cause inflammation, bleeding and sometimes an open sore, called an ulcer. […] Damage from acid can cause changes in the tissue lining the lower esophagus. These changes are associated with an increased risk of esophageal cancer.
  • #81 Extra-Esophageal Manifestations of Gastroesophageal Reflux Disease: Controversies Between Epidemiology and Clicnic
    https://openrespiratorymedicinejournal.com/VOLUME/6/PAGE/121/FULLTEXT/
    Gastroesophageal reflux disease (GERD) is widely associated with asthma, chronic cough, and laryngitis. […] Epidemiological studies have revealed that respiratory problems, such as asthma and cough, are more likely to occur in patients with GERD than in healthy subjects. […] GERD prevalence in patients with asthma has varied widely in different populations, ranging from 30% to 90%. […] In a systematic review that examined 28 studies, a 59.2% weighted-average prevalence of GERD symptoms was observed in patients with asthma, while only 38.1% of controls had these symptoms. […] A very careful study reported by Sontag et al. demonstrated a higher frequency and severity of daytime and nighttime reflux symptoms in asthmatic patients than in appropriate controls. […] In Norway, a recent cohort study in 58,000 subjects reported that asthmatic patients were about 60% more likely to show GERD symptoms than were controls after adjustment for confounding factors.
  • #82 Extra-Esophageal Manifestations of Gastroesophageal Reflux Disease: Controversies Between Epidemiology and Clicnic
    https://openrespiratorymedicinejournal.com/VOLUME/6/PAGE/121/FULLTEXT/
    Gastroesophageal reflux disease (GERD) is widely associated with asthma, chronic cough, and laryngitis. […] Epidemiological studies have revealed that respiratory problems, such as asthma and cough, are more likely to occur in patients with GERD than in healthy subjects. […] GERD prevalence in patients with asthma has varied widely in different populations, ranging from 30% to 90%. […] In a systematic review that examined 28 studies, a 59.2% weighted-average prevalence of GERD symptoms was observed in patients with asthma, while only 38.1% of controls had these symptoms. […] A very careful study reported by Sontag et al. demonstrated a higher frequency and severity of daytime and nighttime reflux symptoms in asthmatic patients than in appropriate controls. […] In Norway, a recent cohort study in 58,000 subjects reported that asthmatic patients were about 60% more likely to show GERD symptoms than were controls after adjustment for confounding factors.
  • #83 Extra-Esophageal Manifestations of Gastroesophageal Reflux Disease: Controversies Between Epidemiology and Clicnic
    https://openrespiratorymedicinejournal.com/VOLUME/6/PAGE/121/FULLTEXT/
    Gastroesophageal reflux disease (GERD) is widely associated with asthma, chronic cough, and laryngitis. […] Epidemiological studies have revealed that respiratory problems, such as asthma and cough, are more likely to occur in patients with GERD than in healthy subjects. […] GERD prevalence in patients with asthma has varied widely in different populations, ranging from 30% to 90%. […] In a systematic review that examined 28 studies, a 59.2% weighted-average prevalence of GERD symptoms was observed in patients with asthma, while only 38.1% of controls had these symptoms. […] A very careful study reported by Sontag et al. demonstrated a higher frequency and severity of daytime and nighttime reflux symptoms in asthmatic patients than in appropriate controls. […] In Norway, a recent cohort study in 58,000 subjects reported that asthmatic patients were about 60% more likely to show GERD symptoms than were controls after adjustment for confounding factors.
  • #84 Reflux Esophagitis Pathology: Definition, Epidemiology, Etiology
    https://emedicine.medscape.com/article/1610393-overview
    Interestingly, a study out of Taiwan by Chen et al showed seasonal variation in the incidence of GERD. Investigators evaluated a total of 76,636 ambulatory care visits for the treatment of GERD between 2001 and 2006 and reported that the incidence of GERD increased in autumn and winter for each sex, age group, as well as combined groups.
  • #85 Meta-analysis on the epidemiology of gastroesophageal reflux disease in China
    https://www.wjgnet.com/1007-9327/full/v28/i45/6410.htm
    Meta-analysis on the epidemiology of gastroesophageal reflux disease in China. The overall pooled prevalence of gastroesophageal reflux disease (GERD) was 8.7% in China. Over the past two decades, the prevalence of GERD in China has increased from 6.0% to 10.6%. GERD was more common in people aged 40-60, with body mass index 24, and of Uygur ethnicity. The prevalence was higher in the west and east than in the centre, and there may be a local spatial autocorrelation between the Qinghai-Tibet Plateau and the southeast. GERD was correlated with gastric (r= 0.421,P = 0.041) and oesophageal tumours (r= 0.511,P = 0.011) in spatial distribution. […] The prevalence of GERD in China is rising. From 6.0% at the beginning of the 21st century to 10.6% at present, there was a significant difference in the prevalence among different periods (P= 0.019). […] The prevalence rate of GERD was higher in people who were over 40 years old, obese and of the Uygur population. The prevalence of GERD was positively correlated with that of oesophageal cancer in terms of spatial distribution.
  • #86 Reflux Esophagitis Pathology: Definition, Epidemiology, Etiology
    https://emedicine.medscape.com/article/1610393-overview
    A Swedish population-based, cross-sectional study compared the prevalence of gastroesophageal reflux symptoms among English and Swedish populations and reported a higher prevalence of reflux symptoms occurring at least twice weekly in English populations compared with Swedish populations. […] With regard to sex-related differences, some studies report no sex predilection. Other studies indicate that males are more likely to develop severe forms of esophagitis and complications such as Barrett esophagus and esophageal adenocarcinoma. Conversely, females are more frequently affected by nonerosive reflux disease (NERD) and symptomatic GERD. The prevalence of reflux esophagitis increases with age, particularly in females after their 50s. […] As noted in adults, there is an increasing trend of GERD in the pediatric population too. Nelson et al reported an increased incidence of GERD that ranged from 12% to 50% in children aged 0-18 years between 2000 and 2005.
  • #87 Epidemiology of Gastroesophageal Reflux Disease in Asia: A Systematic Review
    https://www.jnmjournal.org/view.html?uid=385&vmd=Full
    The prevalence of endoscopic reflux esophagitis in Eastern Asia increased from 3.4%-5.0% before 2000, to 4.3%-15.7% after 2005. […] The prevalence of GERD in Iran was 6.3%-18.3% from 2005 to 2010, which seemed more prevalent than in Eastern Asia. […] The prevalence in Western Asia was found to be the highest among the whole Asian region as represented by 20% in Turkey. […] The prevalence of GERD showed wide range results as followings: 12.4%-31.7% of symptom-based GERD, 2.3%-14.7% of NERD and 7.1%-20.8% of endoscopic reflux esophagitis. […] The prevalence of Barrett’s esophagus was reported as 0.06%-0.84% in medical check-up and 0.31%-2.00% in the referral hospital settings. […] The general low-fat diet of Asian, their smaller body mass and also their higher prevalence of Helicobacter pylori might be related with the lower prevalence of GERD compared to Western peoples.
  • #88 Epidemiology of Gastroesophageal Reflux Disease in Asia: A Systematic Review
    https://www.jnmjournal.org/view.html?uid=385&vmd=Full
    The prevalence of endoscopic reflux esophagitis in Eastern Asia increased from 3.4%-5.0% before 2000, to 4.3%-15.7% after 2005. […] The prevalence of GERD in Iran was 6.3%-18.3% from 2005 to 2010, which seemed more prevalent than in Eastern Asia. […] The prevalence in Western Asia was found to be the highest among the whole Asian region as represented by 20% in Turkey. […] The prevalence of GERD showed wide range results as followings: 12.4%-31.7% of symptom-based GERD, 2.3%-14.7% of NERD and 7.1%-20.8% of endoscopic reflux esophagitis. […] The prevalence of Barrett’s esophagus was reported as 0.06%-0.84% in medical check-up and 0.31%-2.00% in the referral hospital settings. […] The general low-fat diet of Asian, their smaller body mass and also their higher prevalence of Helicobacter pylori might be related with the lower prevalence of GERD compared to Western peoples.
  • #89 English | World Gastroenterology Organisation
    https://www.worldgastroenterology.org/guidelines/gastroesophageal-reflux-disease/gastroesophageal-reflux-disease-english
    GERD is a global disease, and evidence suggests that its prevalence is increasing. Prevalence estimates show considerable geographic variation, but it is only in East Asia that prevalence estimates are currently consistently lower than 10%. The high prevalence of GERD, and hence of troublesome symptoms, has significant societal consequences, impacting adversely on work productivity and many other quality-of-life aspects for individual patients. […] Robust epidemiological studies are still lacking for developed countries, such as Japan, as well as from many emerging economies including Russia, India, and the African continent. There are also few data regarding the prevalence of GERD in pediatric populations, the incidence of GERD, its natural history, and its causes. […] Most epidemiological studies of the condition are symptom-based. As symptom-based diagnosis is challenging, the epidemiological data on the prevalence of gastroesophageal reflux symptoms (GERS) are probably flawed. This is in part because the description and nomenclature of reflux symptoms varies between regions, and in part because upper gastrointestinal symptoms (dyspeptic symptoms) may be described similarly by patients who have a variety of upper gastrointestinal diagnoses, including peptic ulcer disease, nonulcer dyspepsia, dysmotility, or GERD. Nonetheless, it is instructive to report the prevalence of dyspeptic symptoms across the globe, as these data affect the pretest probability that upper gastrointestinal symptoms are attributable to gastroesophageal reflux.
  • #90 English | World Gastroenterology Organisation
    https://www.worldgastroenterology.org/guidelines/gastroesophageal-reflux-disease/gastroesophageal-reflux-disease-english
    GERD is a global disease, and evidence suggests that its prevalence is increasing. Prevalence estimates show considerable geographic variation, but it is only in East Asia that prevalence estimates are currently consistently lower than 10%. The high prevalence of GERD, and hence of troublesome symptoms, has significant societal consequences, impacting adversely on work productivity and many other quality-of-life aspects for individual patients. […] Robust epidemiological studies are still lacking for developed countries, such as Japan, as well as from many emerging economies including Russia, India, and the African continent. There are also few data regarding the prevalence of GERD in pediatric populations, the incidence of GERD, its natural history, and its causes. […] Most epidemiological studies of the condition are symptom-based. As symptom-based diagnosis is challenging, the epidemiological data on the prevalence of gastroesophageal reflux symptoms (GERS) are probably flawed. This is in part because the description and nomenclature of reflux symptoms varies between regions, and in part because upper gastrointestinal symptoms (dyspeptic symptoms) may be described similarly by patients who have a variety of upper gastrointestinal diagnoses, including peptic ulcer disease, nonulcer dyspepsia, dysmotility, or GERD. Nonetheless, it is instructive to report the prevalence of dyspeptic symptoms across the globe, as these data affect the pretest probability that upper gastrointestinal symptoms are attributable to gastroesophageal reflux.
  • #91 English | World Gastroenterology Organisation
    https://www.worldgastroenterology.org/guidelines/gastroesophageal-reflux-disease/gastroesophageal-reflux-disease-english
    GERD is a global disease, and evidence suggests that its prevalence is increasing. Prevalence estimates show considerable geographic variation, but it is only in East Asia that prevalence estimates are currently consistently lower than 10%. The high prevalence of GERD, and hence of troublesome symptoms, has significant societal consequences, impacting adversely on work productivity and many other quality-of-life aspects for individual patients. […] Robust epidemiological studies are still lacking for developed countries, such as Japan, as well as from many emerging economies including Russia, India, and the African continent. There are also few data regarding the prevalence of GERD in pediatric populations, the incidence of GERD, its natural history, and its causes. […] Most epidemiological studies of the condition are symptom-based. As symptom-based diagnosis is challenging, the epidemiological data on the prevalence of gastroesophageal reflux symptoms (GERS) are probably flawed. This is in part because the description and nomenclature of reflux symptoms varies between regions, and in part because upper gastrointestinal symptoms (dyspeptic symptoms) may be described similarly by patients who have a variety of upper gastrointestinal diagnoses, including peptic ulcer disease, nonulcer dyspepsia, dysmotility, or GERD. Nonetheless, it is instructive to report the prevalence of dyspeptic symptoms across the globe, as these data affect the pretest probability that upper gastrointestinal symptoms are attributable to gastroesophageal reflux.
  • #92 Gastroesophageal Reflux Disease (GERD) – Gastrointestinal Disorders – Merck Manual Professional Edition
    https://www.merckmanuals.com/professional/gastrointestinal-disorders/esophageal-and-swallowing-disorders/gastroesophageal-reflux-disease-gerd
    Gastroesophageal reflux disease (GERD) is common. The prevalence varies widely depending on the population being studied; some estimates range from 10 to 20% of adults (1). […] Diagnosis is clinical, sometimes with endoscopy, with or without acid testing. […] Endoscopy, with cytologic washings and/or biopsy of abnormal areas, is the test of choice. Endoscopic biopsy is the only test that consistently detects the columnar mucosal changes of Barrett esophagus. […] Per the Lyon Consensus, grades C and D esophagitis are objective evidence of GERD (2). […] Barrett esophagus may or may not regress with medical or surgical therapy. […] Because Barrett esophagus is a precursor to adenocarcinoma, endoscopic surveillance for malignant transformation is recommended every 3 to 5 years in nondysplastic disease.
  • #93 Gastroesophageal Reflux Disease (GERD) – Gastrointestinal Disorders – Merck Manual Professional Edition
    https://www.merckmanuals.com/professional/gastrointestinal-disorders/esophageal-and-swallowing-disorders/gastroesophageal-reflux-disease-gerd
    Gastroesophageal reflux disease (GERD) is common. The prevalence varies widely depending on the population being studied; some estimates range from 10 to 20% of adults (1). […] Diagnosis is clinical, sometimes with endoscopy, with or without acid testing. […] Endoscopy, with cytologic washings and/or biopsy of abnormal areas, is the test of choice. Endoscopic biopsy is the only test that consistently detects the columnar mucosal changes of Barrett esophagus. […] Per the Lyon Consensus, grades C and D esophagitis are objective evidence of GERD (2). […] Barrett esophagus may or may not regress with medical or surgical therapy. […] Because Barrett esophagus is a precursor to adenocarcinoma, endoscopic surveillance for malignant transformation is recommended every 3 to 5 years in nondysplastic disease.
  • #94 Gastroesophageal Reflux Disease (GERD) – Gastrointestinal Disorders – Merck Manual Professional Edition
    https://www.merckmanuals.com/professional/gastrointestinal-disorders/esophageal-and-swallowing-disorders/gastroesophageal-reflux-disease-gerd
    Gastroesophageal reflux disease (GERD) is common. The prevalence varies widely depending on the population being studied; some estimates range from 10 to 20% of adults (1). […] Diagnosis is clinical, sometimes with endoscopy, with or without acid testing. […] Endoscopy, with cytologic washings and/or biopsy of abnormal areas, is the test of choice. Endoscopic biopsy is the only test that consistently detects the columnar mucosal changes of Barrett esophagus. […] Per the Lyon Consensus, grades C and D esophagitis are objective evidence of GERD (2). […] Barrett esophagus may or may not regress with medical or surgical therapy. […] Because Barrett esophagus is a precursor to adenocarcinoma, endoscopic surveillance for malignant transformation is recommended every 3 to 5 years in nondysplastic disease.
  • #95 Gastroesophageal Reflux Disease (GERD) – Gastrointestinal Disorders – Merck Manual Professional Edition
    https://www.merckmanuals.com/professional/gastrointestinal-disorders/esophageal-and-swallowing-disorders/gastroesophageal-reflux-disease-gerd
    Gastroesophageal reflux disease (GERD) is common. The prevalence varies widely depending on the population being studied; some estimates range from 10 to 20% of adults (1). […] Diagnosis is clinical, sometimes with endoscopy, with or without acid testing. […] Endoscopy, with cytologic washings and/or biopsy of abnormal areas, is the test of choice. Endoscopic biopsy is the only test that consistently detects the columnar mucosal changes of Barrett esophagus. […] Per the Lyon Consensus, grades C and D esophagitis are objective evidence of GERD (2). […] Barrett esophagus may or may not regress with medical or surgical therapy. […] Because Barrett esophagus is a precursor to adenocarcinoma, endoscopic surveillance for malignant transformation is recommended every 3 to 5 years in nondysplastic disease.
  • #96 Gastroesophageal Reflux Disease (GERD) – Gastrointestinal Disorders – Merck Manual Professional Edition
    https://www.merckmanuals.com/professional/gastrointestinal-disorders/esophageal-and-swallowing-disorders/gastroesophageal-reflux-disease-gerd
    Gastroesophageal reflux disease (GERD) is common. The prevalence varies widely depending on the population being studied; some estimates range from 10 to 20% of adults (1). […] Diagnosis is clinical, sometimes with endoscopy, with or without acid testing. […] Endoscopy, with cytologic washings and/or biopsy of abnormal areas, is the test of choice. Endoscopic biopsy is the only test that consistently detects the columnar mucosal changes of Barrett esophagus. […] Per the Lyon Consensus, grades C and D esophagitis are objective evidence of GERD (2). […] Barrett esophagus may or may not regress with medical or surgical therapy. […] Because Barrett esophagus is a precursor to adenocarcinoma, endoscopic surveillance for malignant transformation is recommended every 3 to 5 years in nondysplastic disease.
  • #97 Gastroesophageal Reflux Disease (GERD) – Gastrointestinal Disorders – Merck Manual Professional Edition
    https://www.merckmanuals.com/professional/gastrointestinal-disorders/esophageal-and-swallowing-disorders/gastroesophageal-reflux-disease-gerd
    Gastroesophageal reflux disease (GERD) is common. The prevalence varies widely depending on the population being studied; some estimates range from 10 to 20% of adults (1). […] Diagnosis is clinical, sometimes with endoscopy, with or without acid testing. […] Endoscopy, with cytologic washings and/or biopsy of abnormal areas, is the test of choice. Endoscopic biopsy is the only test that consistently detects the columnar mucosal changes of Barrett esophagus. […] Per the Lyon Consensus, grades C and D esophagitis are objective evidence of GERD (2). […] Barrett esophagus may or may not regress with medical or surgical therapy. […] Because Barrett esophagus is a precursor to adenocarcinoma, endoscopic surveillance for malignant transformation is recommended every 3 to 5 years in nondysplastic disease.
  • #98 Unveiling the intricacies: Insight into gastroesophageal reflux disease
    https://www.wjgnet.com/1007-9327/full/v31/i1/98479.htm
    Gastroesophageal reflux disease (GERD) poses a substantial global health challenge, with prevalence rates exhibiting geographical variation. […] The global prevalence of GERD, despite its widespread discussion, remains uncertain due to several factors. Chief among these is the absence of a universally accepted definition of GERD. […] After reviewing research around the globe, many experts have employed heartburn and/or regurgitation occurring at least once a week as a threshold for GERD. […] GERD is among the most prevalent gastrointestinal motility disorders affecting individuals of all ages and is characterized by a range of uncomfortable symptoms, including chest pain, heartburn, sour taste in the mouth, bad breath (halitosis), vomiting, difficulty swallowing (dysphagia), and respiratory issues.
  • #99 Unveiling the intricacies: Insight into gastroesophageal reflux disease
    https://www.wjgnet.com/1007-9327/full/v31/i1/98479.htm
    Gastroesophageal reflux disease (GERD) poses a substantial global health challenge, with prevalence rates exhibiting geographical variation. […] The global prevalence of GERD, despite its widespread discussion, remains uncertain due to several factors. Chief among these is the absence of a universally accepted definition of GERD. […] After reviewing research around the globe, many experts have employed heartburn and/or regurgitation occurring at least once a week as a threshold for GERD. […] GERD is among the most prevalent gastrointestinal motility disorders affecting individuals of all ages and is characterized by a range of uncomfortable symptoms, including chest pain, heartburn, sour taste in the mouth, bad breath (halitosis), vomiting, difficulty swallowing (dysphagia), and respiratory issues.
  • #100 English | World Gastroenterology Organisation
    https://www.worldgastroenterology.org/guidelines/gastroesophageal-reflux-disease/gastroesophageal-reflux-disease-english
    GERD is a global disease, and evidence suggests that its prevalence is increasing. Prevalence estimates show considerable geographic variation, but it is only in East Asia that prevalence estimates are currently consistently lower than 10%. The high prevalence of GERD, and hence of troublesome symptoms, has significant societal consequences, impacting adversely on work productivity and many other quality-of-life aspects for individual patients. […] Robust epidemiological studies are still lacking for developed countries, such as Japan, as well as from many emerging economies including Russia, India, and the African continent. There are also few data regarding the prevalence of GERD in pediatric populations, the incidence of GERD, its natural history, and its causes. […] Most epidemiological studies of the condition are symptom-based. As symptom-based diagnosis is challenging, the epidemiological data on the prevalence of gastroesophageal reflux symptoms (GERS) are probably flawed. This is in part because the description and nomenclature of reflux symptoms varies between regions, and in part because upper gastrointestinal symptoms (dyspeptic symptoms) may be described similarly by patients who have a variety of upper gastrointestinal diagnoses, including peptic ulcer disease, nonulcer dyspepsia, dysmotility, or GERD. Nonetheless, it is instructive to report the prevalence of dyspeptic symptoms across the globe, as these data affect the pretest probability that upper gastrointestinal symptoms are attributable to gastroesophageal reflux.
  • #101 Increasing global burden of gastro-oesophageal reflux disease | Nature Reviews Gastroenterology & Hepatology
    https://www.nature.com/articles/s41575-020-0298-4
    A systematic review has used data from the Global Burden of Diseases, Injuries and Risk Factors Study to report the burden of gastro-oesophageal reflux disease (GERD) in 195 countries between 1990 and 2017. […] From 144 location-years of prevalence data, a mean estimate of age-standardized prevalence for all locations in 2017 was determined, ranging between 4,40814,035 cases per 100,000 population. […] Although global age-standardized prevalence was stable between 1990 and 2017, the all-age prevalence increased by 18.1%, suggesting that the epidemiology of GERD has not changed but that the burden of disease is increasing as a result of ageing and population growth.
  • #102 Increasing global burden of gastro-oesophageal reflux disease | Nature Reviews Gastroenterology & Hepatology
    https://www.nature.com/articles/s41575-020-0298-4
    A systematic review has used data from the Global Burden of Diseases, Injuries and Risk Factors Study to report the burden of gastro-oesophageal reflux disease (GERD) in 195 countries between 1990 and 2017. […] From 144 location-years of prevalence data, a mean estimate of age-standardized prevalence for all locations in 2017 was determined, ranging between 4,40814,035 cases per 100,000 population. […] Although global age-standardized prevalence was stable between 1990 and 2017, the all-age prevalence increased by 18.1%, suggesting that the epidemiology of GERD has not changed but that the burden of disease is increasing as a result of ageing and population growth.
  • #103 Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis | Scientific Reports
    https://www.nature.com/articles/s41598-020-62795-1
    Although gastro-oesophageal reflux disease (GORD) is a common medical complaint, there is currently no consensus on the global prevalence of GORD. […] The global pooled prevalence of GORD was 13.98% and varied greatly according to region (12.88% in Latin America and the Caribbean to 19.55% in North America) and country (4.16% in China to 22.40% in Turkey). […] Using the United Nations 2017 Revision of World Population Prospects, the estimated number of individuals suffering from GORD globally is 1.03 billion. […] This systematic review and meta-analysis revealed that although a substantial proportion (13.98%) of the global population suffers from GORD, there are significant variations between regions and countries. […] A recent systematic review and meta-analysis conducted by Eusebi et al. 2017 included 108 studies and assessed the global prevalence of, and risk factors for, gastric reflux symptoms rather the prevalence of GORD.
  • #104 Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review | Gut
    https://gut.bmj.com/content/63/6/871
    Objective To update the findings of the 2005 systematic review of population-based studies assessing the epidemiology of gastro-oesophageal reflux disease (GERD). […] Results 16 studies of GERD epidemiology published since the original review were found to be suitable for inclusion (15 reporting prevalence and one reporting incidence), and were added to the 13 prevalence and two incidence studies found previously. The range of GERD prevalence estimates was 18.1%27.8% in North America, 8.8%25.9% in Europe, 2.5%7.8% in East Asia, 8.7%33.1% in the Middle East, 11.6% in Australia and 23.0% in South America. Incidence per 1000 person-years was approximately 5 in the overall UK and US populations, and 0.84 in paediatric patients aged 117years in the UK. Evidence suggests an increase in GERD prevalence since 1995 (p0.0001), particularly in North America and East Asia. […] Conclusions GERD is prevalent worldwide, and disease burden may be increasing. Prevalence estimates show considerable geographic variation, but only East Asia shows estimates consistently lower than 10%.
  • #105 Presentation and Epidemiology of Gastroesophageal Reflux Disease
    https://pmc.ncbi.nlm.nih.gov/articles/PMC5797499/
    In the US, estimates of the prevalence of GERD symptoms have ranged from 6% to 30%, with heterogeneity related to the particular questionnaire used, including the threshold frequency and duration of symptoms required to be classified as GERD. The prevalence of at least weekly GERD symptoms in the US is approximately 20%. […] Importantly, the prevalence of GERD symptoms in North America, Europe, and Southeast Asia has increased approximately 50% relative to the baseline prevalence in the early to middle 1990s, but has plateaued since then. […] There are approximately 110,000 hospital admissions annually in the US for GERD. […] The predominant complications of GERD include dysphagia (including from peptic strictures, Schatzkis rings), bleeding from erosive esophagitis, and esophageal adenocarcinoma.
  • #106 Epidemiology of gastroesophageal reflux disease | WHO FCTC
    https://portal-uat.who.int/fctcapps/fctcapps/fctc/kh/wts/wts-database/epidemiology-gastroesophageal-reflux-disease
    The prevalence of gastroesophageal reflux disease (GERD) symptoms increased approximately 50% until the mid-1990s, when it plateaued. […] The incidence of complications related to GERD including hospitalization, esophageal strictures, esophageal adenocarcinoma, and mortality also increased during that time period, but the increase in esophageal adenocarcinoma has since slowed, and the incidence of strictures has decreased since the mid-1990s. […] GERD is responsible for the greatest direct costs in the United States of any gastrointestinal disease, and most of those expenditures are for pharmacotherapy. […] Risk factors for GERD include obesity, poor diet, lack of physical activity, consumption of tobacco and alcohol, and respiratory diseases.
  • #107 Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis | Scientific Reports
    https://www.nature.com/articles/s41598-020-62795-1
    Stratified pooled prevalence of GORD by BMI showed an increase in GORD prevalence as BMI increased. […] The prevalence of GORD was highest in subjects with low education level (16.78%), followed by those with medium education level (11.52%), and the lowest GORD prevalence was seen in those with a high education level (8.98%). […] When the pooled prevalence of GORD was stratified according to marriage status, the highest prevalence of GORD was found in divorced/separated/widowed individuals (22.95%) followed by married individuals (15.98%), and the lowest GORD prevalence was seen in single individuals (12.85%). […] The pooled prevalence of GORD according to NSAIDs/aspirin use showed a significantly greater prevalence of GORD in subjects using NSAIDs/aspirin (24.47%) compared with those who do not (17.34%).
  • #108 Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis | Scientific Reports
    https://www.nature.com/articles/s41598-020-62795-1
    The area of domicile also had a significant effect on the prevalence of GORD. The pooled prevalence of GORD in subjects living in an urban area was the highest (13.43%) followed by subjects living in a rural area (11.70%). […] The pooled prevalence of GORD according to smoking habits showed that subjects who currently smoke had a higher prevalence of GORD (18.40%) compared with ex-smokers (16.83%) and non-smokers (15.55%). […] Subjects with a low income had a significantly higher prevalence of GORD (11.69%) than those with a medium income (8.42%) and those with a high income (7.68%). […] The effect of dietary intake of certain food and drinks (spicy food, sweet food, meat/fish, carbonated drinks, fatty food, fried food, and coffee/tea) on the pooled prevalence of GORD was also investigated.
  • #109 Presentation and Epidemiology of Gastroesophageal Reflux Disease
    https://pmc.ncbi.nlm.nih.gov/articles/PMC5797499/
    In the US, estimates of the prevalence of GERD symptoms have ranged from 6% to 30%, with heterogeneity related to the particular questionnaire used, including the threshold frequency and duration of symptoms required to be classified as GERD. The prevalence of at least weekly GERD symptoms in the US is approximately 20%. […] Importantly, the prevalence of GERD symptoms in North America, Europe, and Southeast Asia has increased approximately 50% relative to the baseline prevalence in the early to middle 1990s, but has plateaued since then. […] There are approximately 110,000 hospital admissions annually in the US for GERD. […] The predominant complications of GERD include dysphagia (including from peptic strictures, Schatzkis rings), bleeding from erosive esophagitis, and esophageal adenocarcinoma.
  • #110 Diagnostic and therapeutic management in gastroesophageal reflux disease: consensus of the Polish Society of Gastroenterology – Polish Archives of Internal Medicine
    https://www.mp.pl/paim/issue/article/16196/
    Erosive esophagitis was found in 6.4% of patients in China and 15.5% of patients in Sweden in populational studies of patients undergoing endoscopy, regardless of the reported symptoms. […] A prospective study found erosions in the esophagus in 26% of patients with non-erosive reflux disease (NERD) after 2 years, while in another study, erosive esophagitis was found in a follow-up endoscopy after 5 years in 10% of patients. […] GERD is a risk factor for BE, which affects approximately 2% of the population and may progress to esophageal adenocarcinoma. […] GERD increases the risk of esophageal adenocarcinoma (odds ratio [OR], 7.7; 95% CI, 5.311.4), especially in patients with long-term GERD and severe or daily symptoms. […] The risk, however, is low and accounts for less than 0.001% annually. […] The risk of esophageal adenocarcinoma in patients with BE is clearly greater in those with at least low-grade epithelial dysplasia.
  • #111 Extra-Esophageal Manifestations of Gastroesophageal Reflux Disease: Controversies Between Epidemiology and Clicnic
    https://openrespiratorymedicinejournal.com/VOLUME/6/PAGE/121/FULLTEXT/
    Gastroesophageal reflux disease (GERD) is widely associated with asthma, chronic cough, and laryngitis. […] Epidemiological studies have revealed that respiratory problems, such as asthma and cough, are more likely to occur in patients with GERD than in healthy subjects. […] GERD prevalence in patients with asthma has varied widely in different populations, ranging from 30% to 90%. […] In a systematic review that examined 28 studies, a 59.2% weighted-average prevalence of GERD symptoms was observed in patients with asthma, while only 38.1% of controls had these symptoms. […] A very careful study reported by Sontag et al. demonstrated a higher frequency and severity of daytime and nighttime reflux symptoms in asthmatic patients than in appropriate controls. […] In Norway, a recent cohort study in 58,000 subjects reported that asthmatic patients were about 60% more likely to show GERD symptoms than were controls after adjustment for confounding factors.
  • #112 Unveiling the intricacies: Insight into gastroesophageal reflux disease
    https://www.wjgnet.com/1007-9327/full/v31/i1/98479.htm
    Gastroesophageal reflux disease (GERD) poses a substantial global health challenge, with prevalence rates exhibiting geographical variation. […] The global prevalence of GERD, despite its widespread discussion, remains uncertain due to several factors. Chief among these is the absence of a universally accepted definition of GERD. […] After reviewing research around the globe, many experts have employed heartburn and/or regurgitation occurring at least once a week as a threshold for GERD. […] GERD is among the most prevalent gastrointestinal motility disorders affecting individuals of all ages and is characterized by a range of uncomfortable symptoms, including chest pain, heartburn, sour taste in the mouth, bad breath (halitosis), vomiting, difficulty swallowing (dysphagia), and respiratory issues.
  • #113 English | World Gastroenterology Organisation
    https://www.worldgastroenterology.org/guidelines/gastroesophageal-reflux-disease/gastroesophageal-reflux-disease-english
    GERD is a global disease, and evidence suggests that its prevalence is increasing. Prevalence estimates show considerable geographic variation, but it is only in East Asia that prevalence estimates are currently consistently lower than 10%. The high prevalence of GERD, and hence of troublesome symptoms, has significant societal consequences, impacting adversely on work productivity and many other quality-of-life aspects for individual patients. […] Robust epidemiological studies are still lacking for developed countries, such as Japan, as well as from many emerging economies including Russia, India, and the African continent. There are also few data regarding the prevalence of GERD in pediatric populations, the incidence of GERD, its natural history, and its causes. […] Most epidemiological studies of the condition are symptom-based. As symptom-based diagnosis is challenging, the epidemiological data on the prevalence of gastroesophageal reflux symptoms (GERS) are probably flawed. This is in part because the description and nomenclature of reflux symptoms varies between regions, and in part because upper gastrointestinal symptoms (dyspeptic symptoms) may be described similarly by patients who have a variety of upper gastrointestinal diagnoses, including peptic ulcer disease, nonulcer dyspepsia, dysmotility, or GERD. Nonetheless, it is instructive to report the prevalence of dyspeptic symptoms across the globe, as these data affect the pretest probability that upper gastrointestinal symptoms are attributable to gastroesophageal reflux.
  • #114 Increasing global burden of gastro-oesophageal reflux disease | Nature Reviews Gastroenterology & Hepatology
    https://www.nature.com/articles/s41575-020-0298-4
    A systematic review has used data from the Global Burden of Diseases, Injuries and Risk Factors Study to report the burden of gastro-oesophageal reflux disease (GERD) in 195 countries between 1990 and 2017. […] From 144 location-years of prevalence data, a mean estimate of age-standardized prevalence for all locations in 2017 was determined, ranging between 4,40814,035 cases per 100,000 population. […] Although global age-standardized prevalence was stable between 1990 and 2017, the all-age prevalence increased by 18.1%, suggesting that the epidemiology of GERD has not changed but that the burden of disease is increasing as a result of ageing and population growth.